ch3404 asymmetric synthesis of pharmaceuticals and natural ... · • in 1990, dieter seebach (one...

173
Dr Louis C. Morrill School of Chemistry, Cardiff University Main Building, Rm 1.47B [email protected] CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural Products LCM Lectures 1-3 1 For further information see Learning Central: CH3404/Learning Materials/LCM

Upload: others

Post on 27-Mar-2020

10 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Dr Louis C. MorrillSchool of Chemistry, Cardiff University

Main Building, Rm [email protected]

CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural Products

LCM Lectures 1-3

1ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 2: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Central aim of this course:To discuss various aspects of advanced asymmetric synthesis and how these can

be applied towards the production of pharmaceuticals and natural products

Course Outline:

•  Unit 1 – Organocatalysis (LCM)

•  Unit 2 – Enabling tools for organic synthesis (DLB)

•  Unit 3 – Alkene functionalisation (TW)

CH3404 Course Overview

2ForfurtherinformationseeLearningCentral:CH3404/

Page 3: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

•  Lecture 1: Introduction to Organocatalysis; recap of fundamental concepts and definitions; definition of asymmetric catalysis and organocatalysis; historical perspective; α-functionalisation of carbonyl compounds; enamine organocatalytic activation mode (part 1).

•  Lecture 2: HOMO-Raising Organocatalysis; enamine organocatalytic activation mode (part 2): bifunctional vs. steric control; catalyst synthesis and reactivity; dienamine organocatalytic activation mode; C(1)-, C(2)- and C(3)-enolate organocatalytic activation modes.

•  Lecture 3: LUMO-Lowering Organocatalysis; iminium organocatalytic activation mode; iminium-enamine organocatalytic cascades; (α,β-unsaturated) acyl cation organocatalytic activation mode

•  Non-Assessed Feedback Tutorial: Answers to be completed beforehand. Feedback provided during tutorial. Questions on lectures 1 and 2.

•  In Unit 1 we will learn how organocatalysis can be used for a variety of stereo-selective transformations and how this can be applied towards the asymmetric synthesis of pharmaceuticals and natural products.

Unit 1: Lecture Synopsis

3ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 4: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

•  Recommended Reading:1.  Organic Chemistry 2nd Ed. (J. Clayden, N. Greeves and S. Warren, Oxford University

Press, 2012, ISBN 978-0-19-927029-3). Chapter 41 is particularly relevant.2.  Prof. MacMillan Short-Course: www.princeton.edu/chemistry/macmillan/research/

•  Molecular Model Kits: Invaluable for ALL organic chemistry courses. It is highly recommended that you make good use of these to visualise the molecules discussed in this course. You can also use these in your examination if you want to.

•  Learning Central: I have set up a folder on Learning Central that will contain all information for this course including handouts and lecture capture.

•  Non-Assessed Feedback Tutorial: In addition to the questions set, please take advantage of this opportunities to ask questions about any aspect of the course.

•  Me: Should you not be able to find an answer to a question that specifically relates to this course, please email ([email protected]) or visit (1.47B) anytime. In addition, I will specifically keep Monday 4-6pm free each week for office visits.

•  : Indicates worked examples to be performed during lectures.

Unit 1: Additional Resources

4ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 5: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Dr Louis C. MorrillSchool of Chemistry, Cardiff University

Main Building, Rm [email protected]

CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural Products

LCM Lecture 1

1ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 6: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

To best prepare yourself for the contents of this course, please refresh

1st-3rd year undergraduate organic chemistry courses with particular focus on:

Carbonyl chemistry:

•  Addition reactions to aldehydes and ketones

•  Formation of acetals, ketals, imines and enamines

•  Enols and enolates

•  Aldol and Claisen condensations

Stereochemistry including:

•  Assignment of stereocentres

•  Enantiomers and diastereoisomers

Lectures 1-3 Preparation

2ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 7: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Key learning objectives:

•  Recap of fundamental concepts and definitions (stereochemistry)

•  Definition of asymmetric catalysis and organocatalysis

•  The development and introduction of organocatalysis (a historical perspective)

•  Traditional α-functionalisation of carbonyl compounds (HOMO-raising)

•  The enamine organocatalytic activation mode (part 1): definition; general catalytic cycle; intra- and intermolecular aldol reactions; related α-functionalisation reactions; curly arrow pushing mechanisms; stereochemical rationale.

Lecture 1: Introduction to Organocatalysis

3ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 8: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Recap of Fundamental Concepts and Definitions Lecture 1: Introduction to Organocatalysis

4

•  Chirality is a geometric property of some molecules and ions. A chiral molecule/ion is non-superimposable on its mirror image. This section of the course will focus on point chirality.

H

H

H

BrCl

F

H

BrCl

F

Enantiomers

Point Chirality

HO

Me MeCl OH

MeMeCl

Enantiomers

Axial Chirality

CO2H

Enantiomers

Planar Chirality

HO2C

H

H H

H H

H

Helical Chirality

Enantiomers

ForfurtherreadingrefertoOrganicChemistry2ndEd.(J.Claydenetal.)Chapter14pp302-327.

Page 9: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Recap of Fundamental Concepts and Definitions Lecture 1: Introduction to Organocatalysis

5

•  Enantiomers are chiral molecules that are non-superimposable mirror images.

H

BrCl

F

H

BrCl

F

Enantiomers

Point Chirality

H

BrCl

F1

2

3

4

(R)-enantiomer

12

3

4

(S)-enantiomer

H

BrCl

F

•  Diastereomers can occur when there is more than one stereogenic center present

PhOH

PhMe

PhOH

PhMe

Diastereomers(R)

(S) (S)(S)

ForfurtherreadingrefertoOrganicChemistry2ndEd.(J.Claydenetal.)Chapter14pp302-327.

•  Prochiral molecules are those that can be converted from achiral to chiral in a single step. Re or Si for sp2 hybridised centers, labeled at the reacting atom.

PhH

OSi face

Re face

1

2

3

Page 10: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Recap of Fundamental Concepts and Definitions Lecture 1: Introduction to Organocatalysis

6

•  Diastereomeric excess (d.e.) is the excess of one diastereomeric form over another and is often quoted to describe diastereo-selective reactions.

•  Stereo-selective reactions can be both diastereo-selective (favours the formation of one diastereomer) AND enantio-selective (favours the formation of one enantiomer)

•  Enantiomeric excess (e.e.) is the excess of one enantiomeric form over another and is often quoted to describe enantio-selective reactions.

PhPh

O

H H

methylationPh

Ph

O

Me H98% e.e.achiral

compound

PhPh

O

H Me

99:1ratio

PhPh

O

Me

(S) reduction PhOH

PhMe

PhOH

PhMe

95:5ratio

ForfurtherreadingrefertoOrganicChemistry2ndEd.(J.Claydenetal.)Chapter14pp302-327.

Page 11: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Asymmetric CatalysisLecture 1: Introduction to Organocatalysis

7

•  Asymmetric catalysis is a type of catalysis in which a chiral catalyst directs the formation of a chiral compound such that the formation of one particular stereoisomer is favoured.

•  Asymmetric catalysis can be sub-divided into 4 primary areas:

Asymmetric Catalysis

Transition Metal Catalysis

OrganocatalysisMain Group Catalysis

Enzymatic Catalysis

PhPh

O

H H

chiral catalyst

PhPh

O

Me Hreaction

conditions

PhPh

O

MeH

(S) (R)

99% 1%

Enantiomers

achiral compound 98% e.e.

ForfurtherreadingrefertoOrganicChemistry2ndEd.(J.Claydenetal.)Chapter14pp302-327.

Page 12: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis - DefinitionLecture 1: Introduction to Organocatalysis

8ForanoverviewseeD.W.C.MacMillan,Nature,2008,455,304.

•  Organocatalysis is the use of a substoichiometric amount of an organic molecule to increase the rate or a chemical reaction.

•  Substoichiometric – using less than 1 equivalent of reagent = catalytic. For example, if you use 0.2 equiv of a catalyst (20 mol%), this equates to 5 turnovers.

•  Organic molecule – there are no metal(s) present within the catalyst.

•  Increase the rate – via lowering the activation barrier for productive reaction.

Reaction Coordinate

FreeEnergy

(G)

Ea (no catalyst)

Starting Materials

Products

Ea (catalyst)

NNN Ph

O

NH

PhPh

OTMSN

OMe

N

OH

P Ph

Page 13: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – A Historical PerspectiveLecture 1: Introduction to Organocatalysis

9ForanoverviewseeD.W.C.MacMillan,Nature,2008,455,304.

•  Since the year 2000, there has been an explosion of interest in this exciting new field.

•  Between 2000 and 2008, there were more than 2000 manuscripts on >150 discrete reaction types.

•  However, there were several pioneering reports of metal-free catalysis prior to the year 2000, which laid the foundations for further development.

Page 14: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – A Historical PerspectiveLecture 1: Introduction to Organocatalysis

10J.Liebig,Ann.Chem.Pharm.,1860,13,246.

•  The first organocatalytic transformation was reported in 1860 by Justus von Liebig in the conversion of cyanogen to oxamide in the presence of aqueous acetaldehyde.

•  This reaction satisfies the definition of an organocatalytic process:

1) The reagent is substoichiometric (20 mol%), therefore it is a catalyst.

2) There is no metal present within the catalyst, therefore it is an organocatalyst.

3) No reaction occurs without acetaldehyde, therefore it increases the rate.

•  Let’s consider the curly arrow pushing mechanism of this organocatalytic reaction.

C C NNCyanogen

H2N

ONH2

OOxamide

H

O

Me(20 mol%)

H2O

Page 15: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – A Historical PerspectiveLecture 1: Introduction to Organocatalysis

11J.Liebig,Ann.Chem.Pharm.,1860,13,246.

•  The conversion of cyanogen to oxamide in the presence of aqueous acetaldehyde.

C C NN H2N

ONH2

O

H

O

Me(20 mol%)

H2O

Page 16: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – A Historical PerspectiveLecture 1: Introduction to Organocatalysis

12J.Liebig,Ann.Chem.Pharm.,1860,13,246.

•  From the curly arrow pushing mechanism we can conclude that acetaldehyde acts as an organocatalyst by increasing the electrophilicity of the nitrile functional group towards nucleophilic attack by a water molecule.

C C NNH

O

MeC C NN

Me

OH

δ+

Increased δ+

more electrophilic

C C NNMe

OH

H2O

δ+

Promotes nucleophilicattack of H2O

(lowers activation barrier)

•  When presented with any organocatalytic reaction we must consider:

1)  The curly arrow pushing mechanism

2)  How the organocatalyst activates the substrate towards a given reaction (activation mode)

3)  The stereochemical outcome of the reaction (if relevant)

Page 17: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – A Historical PerspectiveLecture 1: Introduction to Organocatalysis

13Z.G.Hajosetal.,J.Org.Chem.,1974,39,1615.

•  Over 100 years later, in 1974, L-proline was discovered as an organocatalyst for the intramolecular asymmetric aldol reaction.

•  This reaction employs a chiral catalyst and hence the reaction is catalytic AND asymmetric.

•  One stereoisomer of the product is favoured due to the use of a chiral catalyst.

•  Due to the presence of two stereogenic centres within the product, both enantiocontrol (e.e.) and diastereocontrol (d.e.) are important considerations.

•  We will revisit this landmark reaction in detail later in the lecture.

Me

O

Me

O

O NH

CO2H

(3 mol%)DMF

O

O

Me

OH

Bicycle>90% d.e. 97% e.e.

Page 18: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – A Historical PerspectiveLecture 1: Introduction to Organocatalysis

14ForanoverviewseeD.W.C.MacMillan,Nature,2008,455,304.

•  Despite the clear precedence within the literature, the chemical synthesis community continued to largely overlook the field of organocatalysis for a further 26 years.

•  Why did the field of chemical synthesis overlook the use of organic catalysts until the beginning of the 21st century?

L-Proline as catalyst Sporadic Reports

Page 19: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – A Historical PerspectiveLecture 1: Introduction to Organocatalysis

15D.Seebach,Angew.Chem.Int.Ed.,1990,29,1320.

•  In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic synthesis and stated: “New synthetic methods are most likely to be encountered in the fields of biological and organometallic chemistry”

•  Why did he omit organocatalysis from his vision of the future of organic synthesis?

•  One interesting perspective is that it is impossible to overlook a field that does not yet exist! (in much the same way that you cannot work on a problem that has not yet been defined)

Page 20: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – A Historical PerspectiveLecture 1: Introduction to Organocatalysis

16B.Listetal.,J.Am.Chem.Soc.,2000,122,2395;D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2000,122,4243.

•  What happened in the year 2000 that resulted in a explosion of interest in this area of research?

•  In 2000, two landmark reports from List and MacMillan conceptualised the field, paving the way for others to contribute. Both are likely future Nobel Prize recipients!

L-Proline as catalyst ?Sporadic Reports

Page 21: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – A Historical PerspectiveLecture 1: Introduction to Organocatalysis

17B.Listetal.,J.Am.Chem.Soc.,2000,122,2395;D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2000,122,4243.

•  List reported a proline-catalysed asymmetric intermolecular aldol reaction

•  We will revisit both of these landmark reactions in detail later in the course.

•  MacMillan reported a enantioselective organocatalytic Diels-Alder reaction

(5 mol%)

MeOH-H2O

O

H

N

NH Me

Me

MeO

Bn

CHO

cycloadduct82% yield88% d.e.94% e.e.

+

NH

CO2H

(30 mol%)DMSOi-Pr H

O

Me

O

Me

β-hydroxy ketone97% yield96% e.e.

+i-Pr Me

OOH

Page 22: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – A Historical PerspectiveLecture 1: Introduction to Organocatalysis

18D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2000,122,4243.

•  MacMillan’s manuscript conceptualised the field of organocatalysis for the first time in 3 important ways

•  Introduced terms “organocatalytic” and “organocatalysis” for the first time.

•  Outlined the potential benefits of using organic molecules as asymmetric catalysts for industry or academia.

•  Introduced the concept of a generic mode of activation for organic catalysts that could be used of over many reaction types.

Page 23: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – A Historical PerspectiveLecture 1: Introduction to Organocatalysis

19B.Listetal.,J.Am.Chem.Soc.,2000,122,2395;D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2000,122,4243.

•  There are several inherent benefits of using organic molecules as catalysts:

1)  Low air and moisture sensitivity – operationally easy to handle.

2)  Inexpensive and easy to prepare with both enantiomers commonly available.

3)  Starting materials are readily available from the chiral pool, e.g. amino acids.

4)  Non-toxic and easily removed from waste streams

•  The pioneering reports of List and Macmillan have resulted in organocatalysis being thoroughly established as the 4th main branch of asymmetric catalysis.

Asymmetric Catalysis

Transition Metal Catalysis

OrganocatalysisMain Group Catalysis

Enzymatic Catalysis

Page 24: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – General ClassificationsLecture 1: Introduction to Organocatalysis

20ForanexcellentoverviewseeB,Listetal.,Org.Biomol.Chem.,2005,3,719.

•  Organocatalysts are commonly divided into 4 main sub-classes: Lewis bases, Lewis acids, Brønsted bases and Brønsted acids:

Organocatalysis

Lewis Acid Catalysis

Brønsted Acid CatalysisBrønsted Base Catalysis

Lewis Base Catalysis

•  Lewis bases – able to donate a lone pair of electrons

•  Lewis acids – able to accept a lone pair of electrons

•  Brønsted bases – able to accept a proton

•  Brønsted acids – able to donate a proton

•  This course will focus exclusively on Lewis base organocatalysts.

Page 25: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalysis – The Picture TodayLecture 1: Introduction to Organocatalysis

21ForanexcellentoverviewseeD.Romoetal.,Nat.Prod.Rep.,2014,31,1318.

•  Organocatalysis is now a thoroughly established member of the synthetic toolbox, with a large number of generic activation modes known.

Covalent Activation Modes Non-Covalent Activation Modes

R2

N

Enamine (di-, tri-, tetra-enamine) Catalysis

R2

N

Iminium Catalysis

R1 R2

O

Phosphine Catalysis

R1

P

Cat

O

C(1)-Enolate (di-enolate)Catalysis

Cat

O

Acyl ammonium/azoliumCatalysis

R1

R1

R1

OH

N-Heterocyclic Carbene Catalysis

R1

RN

RN

CatO

R1

C(2)-EnolateCatalysis

O

R1

C(3)-EnolateCatalysis

Cat R2

N

SOMO CatalysisR1

R1 R2

XR2

HO

PO

Brønsted AcidCatalysis

R1 R2

XR

Phase-transferCatalysis

NR4

R1 R2

XR2

OP

O

Chiral AnionCatalysis

R1 R2

X

Hydrogen BondingCatalysis

H HRN NR

S

•  This course will focus exclusively on covalent activation modes, which all employ Lewis base organocatalysts.

Page 26: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Functionalisation of Carbonyl CompoundsLecture 1: Introduction to Organocatalysis

22

•  How can we functionalise the α-position of an aldehyde or ketone?

•  A commonly employed method is to deprotonate at the α-position with a suitable base (e.g. lithium diisopropylamide (LDA)) to form a metal bound enolate.

•  This enolate is nucleophilic and can react with an electrophile at the α-position. This is often described as raising the energy of the HOMO (increasing nucleophilicity)

•  In certain cases, this can form a new stereogenic center.

R2

O

R1R2

O

R1

E *

R2

O

R1

M

E

α?

ForfurtherreadingrefertoOrganicChemistry2ndEd.(J.Claydenetal.)Chapter20pp449-470.

Page 27: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Functionalisation of Carbonyl CompoundsLecture 1: Introduction to Organocatalysis

23

•  How can we functionalise the α-position of an aldehyde or ketone?

•  An alternative option involves the use of a secondary amine (e.g. pyrrolidine) to generate an enamine.

•  This enamine is also nucleophilic (HOMO-raised) and can react with an electrophile at the α-position.

•  In certain cases, this can form a new stereogenic center.

R2

O

R1R2

O

R1

E *α

NH

-H2O R2

N

R1

ER2

N

R1

E * +H2O

NH

?

G.Storketal.,J.Am.Chem.Soc.,1954,76,2029.

Page 28: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Functionalisation of Carbonyl CompoundsLecture 1: Introduction to Organocatalysis

24

•  Enamines are versatile nucleophiles and can react with a broad range of electrophiles, e.g. Michael acceptors, alkyl halides, acid chlorides etc.

N Acylation

O O

Ph

Michael Addition

OCN

Alkylation

OMe

O

Ph

CNCl Ph

O

Me IBn Br

•  All products shown are after hydrolysis. We must be able to draw curly arrow pushing mechanisms for all transformations.

•  We will go through one now in detail on the visualiser.

G.Storketal.,J.Am.Chem.Soc.,1954,76,2029.

Page 29: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Functionalisation of Carbonyl CompoundsLecture 1: Introduction to Organocatalysis

25

•  How can we functionalise the α-position of an aldehyde or ketone?

•  The secondary amine is regenerated, providing the basis for a catalytic system.

R2

O

R1R2

O

R1

E *α

NH

-H2O R2

N

R1

ER2

N

R1

E * +H2O

NH

?

R2

O

R1R2

O

R1

E *α

NH

(cat.)+ EEnamine Catalysis

B.Listetal.,Chem.Rev.,2007,107,5471.

Page 30: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enamine OrganocatalysisLecture 1: Introduction to Organocatalysis

26B.Listetal.,Chem.Rev.,2007,107,5471.

•  We will start by looking at the most widely explored activation mode – enamine organocatalysis.

•  The enamine activation mode has the following key characteristics:

1)  It is a covalent activation mode – the catalyst is covalently bound to the substrate.

2)  It is a nucleophilic (HOMO-raised) activation mode – it reacts with electrophiles.

3)  It employs primary and secondary amine Lewis base organocatalysts and enolisable aldehyde/ketone substrates.

R1R3

N

R2

E

Enamine Organocatalysis

Page 31: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enamine Organocatalysis – General MechanismLecture 1: Introduction to Organocatalysis

27

•  We can draw the following catalytic cycle for enamine organocatalysis:

B.Listetal.,Chem.Rev.,2007,107,5471.

NH

N

R1

R2

N

R1

R2E

R2

N

R1

E *

R2

O

R1

H2OH2O

R2

O

R1

E *

Amine

Iminium

Enamine

Iminium

Page 32: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enamine Organocatalysis – General MechanismLecture 1: Introduction to Organocatalysis

28

•  We can also imagine using a chiral secondary amine for asymmetric organocatalysis

B.Listetal.,Chem.Rev.,2007,107,5471.

NH

N

R1

R2

N

R1

R2E

R2

N

R1

E *

R2

O

R1

H2OH2O

R2

O

R1

E *

Amine

Iminium

Enamine

Iminium

Page 33: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intramolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

29

•  Let’s revisit the pioneering work of Z. G. Hajos et al.:

Z.G.Hajosetal.,J.Org.Chem.,1974,39,1615.

•  For this class of organocatalytic reaction we must be able to:

1)  Know how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  Rationalise the stereochemical outcome of the reaction (both diastereo- and enantiocontrol in this case) by drawing an appropriate transition state.

Me

O

Me

O

O NH

CO2H

(3 mol%)DMF

O

O

Me

OH

Bicycle>90% d.e. 97% e.e.

Page 34: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intramolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

30

•  First let’s consider the organocatalytic activation mode:

Z.G.Hajosetal.,J.Org.Chem.,1974,39,1615.

•  We have the following information:

1)  A secondary amine Lewis base organocatalyst is used

2)  The substrate contains three ketone functional groups, one of which is less hindered than the other two (and hence most reactive)

3)  The least hindered ketone is enolisable (e.g. it has α-hydrogen atoms that can be deprotonated)

•  Conclusion – this reaction proceeds via the enamine activation mode.

Me

O

Me

O

O NH

CO2H

(3 mol%)DMF

O

O

Me

OH

Bicycle>90% d.e. 97% e.e.

Page 35: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intramolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

31

•  Let’s think about the key nucleophilic enamine species formed in detail:

Z.G.Hajosetal.,J.Org.Chem.,1974,39,1615.

•  (E)-configuration and conformation on the left is most stable, BUT all enamines shown above would react to give a 4-membered ring – less favoured pathway!

Me

O

Me

O

O NH

CO2H

H2O

MeR

N CO2H

(Z)-enamine

Me

N CO2H

(E)-enamineR

Me

N

Me

O

OCO2H

NR

Me

(Z)-enamine

Me

N

(E)-enamineR

CO2H CO2H

H

HH

H

HH

1 2

Deprotonationat position 2

2 possible configurationseach with 2 conformations

Page 36: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intramolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

32

•  Let’s think about the key nucleophilic enamine species formed in detail:

Z.G.Hajosetal.,J.Org.Chem.,1974,39,1615.

•  Enamine conformation on the left is most stable, and both enamines shown would react to give a 6-membered ring – more favoured pathway!

•  Remember, all iminium and enamine formations are all reversible.

Me

O

Me

O

O NH

CO2H

H2O

R

N CO2H

Me

N

Me

O

OCO2H

R

N CO2H

1 2

Deprotonationat position 1

H

HH

Hreactive enamine

2 enamine conformations

Page 37: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intramolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

33

•  Now let’s consider the curly arrow pushing mechanism:

Z.G.Hajosetal.,J.Org.Chem.,1974,39,1615.

•  We must always draw the curly arrows for every step of the mechanisms (including enamine formation/hydrolysis).

Me

O

Me

O

O NH

CO2H

(3 mol%)DMF

O

O

Me

OH

Bicycle>90% d.e. 97% e.e.

Me

O

ON CO2HO

N

Me

OH

HO2C

- H2O + H2O

Page 38: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intramolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

34

•  Finally, let’s rationalise the stereochemical outcome of the reaction:

Z.G.Hajosetal.,J.Org.Chem.,1974,39,1615.

•  Conformation such that intramolecular hydrogen bond can occur, which stabilises the transition state. Can see that hydroxyl and methyl groups are on the same side.

Me

O

ON CO2H

1 23

45

6

redraw

N

O

OO H

O

Me1

2 3 4

6 5

OO H

O

Me3 4

51

26

O

O

Me

OH

Reaction

Reaction

redraw

34

5

1

26

ketoneSi-face

exposed(after hydrolysis) (S) (S)

(S)(S)

Page 39: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

35

•  Now let’s consider the intermolecular process reported by B. List et al.:

B.Listetal.,J.Am.Chem.Soc.,2000,122,2395

•  For this class of organocatalytic reaction we must be able to:

1)  Know how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  Rationalise the stereochemical outcome of the reaction (only enantiocontrol is relevant in this case) by drawing an appropriate transition state.

NH

CO2H

(30 mol%)DMSOi-Pr H

O

Me

O

Me

β-hydroxy ketone97% yield96% e.e.

+i-Pr Me

OOH

Page 40: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

36

•  First let’s consider the organocatalytic activation mode:

B.Listetal.,J.Am.Chem.Soc.,2000,122,2395

•  We have the following information:

1)  A secondary amine Lewis base organocatalyst is used

2)  One reactant contains a ketone functional group and the other contains an aldehyde functional group.

3)  Both the aldehyde and ketone are enolisable (e.g. they have α-hydrogen atoms that can be deprotonated)

•  Conclusion – this reaction proceeds via the enamine activation mode.

NH

CO2H

(30 mol%)DMSOi-Pr H

O

Me

O

Me

β-hydroxy ketone97% yield96% e.e.

+i-Pr Me

OOH

Page 41: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

37

•  Let’s think about the key nucleophilic enamine species formed in detail:

B.Listetal.,J.Am.Chem.Soc.,2000,122,2395

•  Ketone-derived enamine is formed in preference to the aldehyde-derived enamine.

NH

CO2H

H2O Me

N

Me

CO2H

Me

O

Me

2 enamine conformations

Me

N CO2H

Me

N CO2H

H

HH

H

reactive enamine

H

N CO2H

Me

Me

i-Pr H

O+

α-branched aldehyde-derived enaminesmore steric congestion / harder to form

NH

CO2H

H2OH

N CO2H

Me

Me

2 enamine conformations

N CO2H

HMe

Me

HH

Page 42: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

38

•  Now let’s consider the curly arrow pushing mechanism:

B.Listetal.,J.Am.Chem.Soc.,2000,122,2395

•  From inspection of the product it is clear that acetone becomes the nucleophile and that isobutyraldehyde is the electrophile.

NH

CO2H

(30 mol%)DMSOi-Pr H

O

Me

O

Me

β-hydroxy ketone97% yield96% e.e.

Me

N CO2H

- H2O + H2O

i-Pr

O

H i-Pr Me

N

+

OH CO2H

i-Pr Me

OOH

Page 43: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

39

•  Finally, let’s rationalise the stereochemical outcome of the reaction:

B.Listetal.,J.Am.Chem.Soc.,2000,122,2395

•  Conformation such that intermolecular hydrogen bond can occur, which stabilises the transition state.

•  Must place large i-Pr group in pseudoequatorial position to lower the energy. Assign the stereocentre before and after redrawing to convince yourself that it is correct.

Me

redraw

Reaction

Reaction

redraw

O H

N

OO

i-Pr

HMe

O H

Oi-Pr

H(R)

(R)

aldehyde Re-face exposed

i-Pr Me

OOH

Me

N CO2H

i-Pr

O

H+

(after hydrolysis)

Page 44: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

40

•  This reaction using acetone in DMSO is limited to the use of α-branched aldehydes:

B.Listetal.,J.Am.Chem.Soc.,2000,122,2395

•  Which other products might form when using unbranched aldehydes in this reaction? (hint: self-aldolisation)

•  In all cases, careful consideration of the mechanism will reveal useful information.

NH

CO2H

(30 mol%)DMSOMeMe

O

H

O

R Me

O

R

OHβ-hydroxy ketones

Examples

Me

OOH

62% yield60% e.e.

Me

OOH

54% yield77% e.e.

Me

OOH

81% yield>99% e.e.

+

Page 45: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Application Towards Natural Product SynthesisLecture 1: Introduction to Organocatalysis

41

•  Performing the reaction in acetone as the solvent allowed the cross aldol reaction with α-unbranched aldehydes in modest yields. This was applied towards the synthesis of the bark beetle pheromone (S)-ipsenol.

B.Listetal.,Org.Lett.,2001,3,573

NH

CO2H

(10 mol%)AcetoneMeMe

O

H

O

Me

OOH β-hydroxy ketone34% yield73% e.e.

Application

i-Pr + i-Pr

Me

OOHi-Pr

i) TBSCl, Imidazole

ii) KHMDS

NCl N

Tf

Tf

OTfOTBSi-Pr

SnBu3Pd(PPh3)4 (2 mol%)

LiCl, THF95% yield

OTBSi-Pr

TBAF

57% yield

90% yieldOH

i-Pr(S)-ipsenol

Page 46: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

42

•  In 2002, MacMillan developed a proline-catalysed self-aldolisation reaction:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2002,124,6798

•  Why does the product not react again with another equivalent of the aldehyde?

•  The diastereoselectivity for this reaction is quite low. How might this be improved?

NH

CO2H

(10 mol%)DMFH

O

H

O OHβ-hydroxy-α-alkyl aldehydes

80% yield60% d.e.

99% e.e. (anti)MeH

O

Me Me Me

H

N CO2H

reactive enamine

O H

N

OO

Et

H

MeReaction

OHO

Et

H

Me(after

hydrolysis) H

H H

(S)

(S)

(S)(S)

Me

aldehyde Re-face exposed

enamine Re-face exposed

+

Page 47: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

43

•  Let’s think about the key nucleophilic enamine species formed in detail:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2002,124,6798

•  The (E)-configuration is favoured over the (Z)-configuration due to steric congestion involving the methyl substituent. One (E)-conformation is also favoured over the other

H

O

Me

NH

CO2H -H2O

H

N CO2H

MeH

N CO2H

MeN CO2H

MeH

N CO2H

HMe

HH

HH

(E)-enamine(E)-enamine (Z)-enamine (Z)-enamine

2 possible configurationseach with 2 conformations

H H

Page 48: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Aldol Reaction Lecture 1: Introduction to Organocatalysis

44

•  Protocol also works for cross-aldol reactions with slow addition of donor aldehyde:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2002,124,6798

•  Why do we need to keep the local concentration of the donor aldehyde low?

•  What other products might be expected in the second reaction?

NH

CO2H

(10 mol%)DMFH

O

H

O OH82% yield>90% d.e.

99% e.e. (anti)MeH

O

Me Me Me(1 equiv) (2 equiv)

Me+ Me

NH

CO2H

(10 mol%)DMFH

O

H

O OH88% yield50% d.e.

99% e.e. (anti)MeH

O

Me

i-Pr+ i-Pr

Donor

Donor Acceptor

Acceptor

Page 49: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Aldol Reaction – Class ExampleLecture 1: Introduction to Organocatalysis

45

•  Determine the major product for the reaction shown below:

D.W.C.MacMillanetal.,Angew.Chem.Int.Ed.,2004,43,2152

•  A number of different protecting groups can be incorporated (Bn, PMB, TIPS)

•  These building blocks have been applied towards enantio-selective carbohydrate synthesis.

NH

CO2H

(10 mol%)DMSOH

O

OBnH

O

OBn

+

Page 50: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantio-Selective Carbohydrate SynthesisLecture 1: Introduction to Organocatalysis

46

•  The products formed were transformed to carbohydrates in 1 step:

D.W.C.MacMillanetal.,Science.,2004,305,1752

•  Merging catalytic technologies allows enantio- and diastereoselective access to fully differentiated carbohydrates in only two chemical steps – amazing!

H

O OH

OTIPS OTIPS

glucose derivative79% yield80% d.e.95% e.e.

MgBr2(10 mol%)

Et2OH

OSiMe3

OAc +O OH

OH

TIPSO

OAcTIPSO

H

O OH

OTIPS OTIPS

mannose derivative87% yield>90% d.e.95% e.e.

MgBr2(10 mol%)

CH2Cl2H

OSiMe3

OAc +O OH

OH

TIPSO

OAcTIPSO

H

O OH

OTIPS OTIPS

α-allose derivative87% yield>90% d.e.95% e.e.

TiCl4(10 mol%)

CH2Cl2H

OSiMe3

OAc +O OH

OH

TIPSO

OAcTIPSO

Page 51: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Mannich Reaction Lecture 1: Introduction to Organocatalysis

47

•  Replacing the aldehyde with an imine electrophile allowed an enantio-selective Mannich reaction to be developed by B. List et al.:

B.Listetal.,J.Am.Chem.Soc.,2000,122,9336

•  For this class of organocatalytic reaction we must be able to:

1)  Know how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  Rationalise the stereochemical outcome of the reaction (diastereo- and enantiocontrol are relevant in this case) by drawing an appropriate transition state.

NH

CO2H

(35 mol%)DMSOMe

O

H

N

Me

O HN 93% yield>90% d.e.98% e.e.

NO2

MeO

+

NO2

OMe

OMe OMe

Page 52: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Mannich Reaction Lecture 1: Introduction to Organocatalysis

48

•  First let’s consider the organocatalytic activation mode:

B.Listetal.,J.Am.Chem.Soc.,2000,122,9336

•  We have the following information:

1)  A secondary amine Lewis base organocatalyst is used

2)  One reactant contains a ketone functional group and the other contains an imine (or more specifically an aldimine) functional group.

3)  The ketone is enolisable (e.g. it has α-hydrogen atoms that can be deprotonated)

•  Conclusion – this reaction proceeds via the enamine activation mode.

NH

CO2H

(35 mol%)DMSOMe

O

H

N

Me

O HN 93% yield>90% d.e.98% e.e.

NO2

MeO

+

NO2

OMe

OMe OMe

Page 53: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Mannich Reaction Lecture 1: Introduction to Organocatalysis

49

•  Let’s think about the key nucleophilic enamine species formed in detail:

B.Listetal.,J.Am.Chem.Soc.,2000,122,9336

•  Here, we can deprotonate at the methyl group or at the methylene position.

•  Deprotonation at the methyl group gives rise to less stable di-substituted enamines. These will not be the major (reactive) enamine forms.

NH

CO2H -H2Odeprotonation

at the methyl group

Me

O

OMe

N CO2HN CO2H

OMe OMe

Hdisubstituted enamines

less stable enamine form

Page 54: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Mannich Reaction Lecture 1: Introduction to Organocatalysis

50

•  Let’s think about the key nucleophilic enamine species formed in detail:

B.Listetal.,J.Am.Chem.Soc.,2000,122,9336

•  Deprotonation at the methylene position gives rise to more stable tri-substituted enamines. The less sterically congested (E)-enamine will be the major (reactive) enamine form.

Me

N CO2H

OMeMe

N CO2H

MeON CO2H

OMeMe

N CO2H

MeOMe

HH

HH

(E)-enamine(E)-enamine (Z)-enamine (Z)-enamineH H

NH

CO2H -H2O deprotonationat the methylene position

Me

O

OMe

Page 55: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Mannich Reaction Lecture 1: Introduction to Organocatalysis

51

•  Now let’s consider the curly arrow pushing mechanism:

B.Listetal.,J.Am.Chem.Soc.,2000,122,9336

•  From inspection of the product it is clear that the ketone becomes the nucleophile and that the imine is the electrophile.

NH

CO2H

(35 mol%)DMSOMe

O

H

N

Me

O HN 93% yield>90% d.e.98% e.e.

NO2

MeO

+

NO2

OMe

OMe OMe

NHO2C

- H2O + H2O

H

N

ArMe

N

Ar

NHPMPMe

OMe

PMPHO2C

OMe

Page 56: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Intermolecular Asymmetric Mannich Reaction Lecture 1: Introduction to Organocatalysis

52

•  Finally, let’s rationalise the stereochemical outcome of the reaction:

B.Listetal.,J.Am.Chem.Soc.,2000,122,9336

•  Conformation such that intermolecular hydrogen bond can occur, stabilising the transition state. This forces the large Ar and PMP groups into pseudoaxial positions.

•  Assign the two stereocentres before and after redrawing to convince yourself that they are both correct.

Me

redraw

Reaction

Reaction

redraw

N H

N

OO

H

Ar(R)

(R)

N CO2H

H

N

ArMeOMe

PMP

MeOPMP

MeNH

OH

Ar

MeOPMP

H(S)

Me

O

Ar

HNPMP

OMe

(S)

enamine Si-face exposed

imine Si-face exposed

H

+

(after hydrolysis)

Page 57: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Predictable Stereochemistry for Aldol and MannichLecture 1: Introduction to Organocatalysis

53

•  Use of proline leads to anti-aldol or syn-Mannich:

B.Listetal.,Chem.Rev.,2007,107,5471.

•  Proline is often described as a bifunctional catalyst as it:

1)  Activates the aldehyde/ketone substrate via enamine formation.2)  Activates the electrophilic component by hydrogen bonding.

RO H

N

OO

R2

H

R1

HAldol Reaction

anti-selective R

O

R2

OH

R1

RN H

N

OO

H

R2

R1PMP

Mannich Reaction

syn-selective R

O

R2

NHPMP

R1

Proline BifunctionalActivation

RX Y H

N

OO

R1

H

H

Page 58: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Bifunctional Enamine CatalysisLecture 1: Introduction to Organocatalysis

54

•  Proline has been used as a bifunctional organocatalyst for many related processes:

K.A.Jørgensenetal.,J.Am.Chem.Soc.,2002,124,6254.

•  The α-amination of ketones was reported by K. A. Jørgensen et al., using diethyl azodicarboxylate (DEAD) as the electrophile.

•  The proline catalyst activates the ketone substrate and the electrophile (bifunctional).

NH

CO2H

(10 mol%)DCEMe

O

NN

CO2EtMe

ON

CO2Et

HN α-amino ketone80% yield95% e.e.

Me

+EtO2C

Me

CO2Et

MeN N H

N

OOCO2Et

MeCO2Et

H(R)

Reaction

MeN NH

O

CO2Et

MeCO2Et

H

(R)

(after hydrolysis)

enamine Re-face exposed

Page 59: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Bifunctional Enamine CatalysisLecture 1: Introduction to Organocatalysis

55

•  Proline has been used as a bifunctional organocatalyst for many related processes:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2003,125,10808.

•  The α-oxidation of aldehydes was reported by D. W. C. MacMillan et al., using nitrosobenzene as the electrophile.

•  The proline catalyst activates the aldehyde and the electrophile (bifunctional).

NH

CO2H

(2 mol%)CHCl3H

O

NO

Ph H

OO

HN α-hydroxy aldehyde88% yield97% e.e.

Me

+

Me

Ph

HO N H

N

OO

MePh

H(R)

Reaction

HO NH

OMePh

H

(R)

(after hydrolysis)

enamine Re-face exposed

Page 60: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Key learning objectives:

•  Recap of fundamental concepts and definitions (stereochemistry)

•  Definition of asymmetric catalysis and organocatalysis

•  The development and introduction of organocatalysis (a historical perspective)

•  Traditional α-functionalisation of carbonyl compounds

•  The enamine organocatalytic activation mode (part 1): definition; general catalytic cycle; intra- and intermolecular aldol reactions; related α-functionalisation reactions; curly arrow pushing mechanisms; stereochemical rationale.

Lecture 1: Introduction to Organocatalysis

56ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 61: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

To reinforce your understanding of the contents of this lecture, please refer to:

•  Organic Chemistry 2nd Ed. (J. Clayden, N. Greeves and S. Warren, Oxford University Press, 2012, ISBN 978-0-19-927029-3). Chapter 41 is particularly relevant.

•  New Frontiers in Asymmetric Catalysis (K. Mikami and M. Lautens, Wiley, 2007). Downloadable from University Network. DOI: 10.1002/0470098007

•  Catalytic Asymmetric Synthesis 3rd Ed. (I. Okima, Wiley, 2010). Downloadable from University Network. DOI: 10.1002/9780470584248

•  Prof. MacMillan Short-Course: www.princeton.edu/chemistry/macmillan/research/

•  A leading review article on enamine organocatalysis: Chem. Rev., 2007, 107, 5471.

•  CH3404 Feedback Workshop

Lecture 1 Revision

57ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 62: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Dr Louis C. MorrillSchool of Chemistry, Cardiff University

Main Building, Rm [email protected]

CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural Products

LCM Lecture 2

1ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 63: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Key learning objectives:

•  The enamine organocatalytic activation mode (part 2): Bifunctional vs. steric control; synthesis and reactivity of imidazolidinone and diarylprolinol silyl ether organocatalysts.

•  Dienamine organocatalytic activation mode.

•  Alternative HOMO-raising organocatalytic activation modes.

•  C(1)-, C(2)- and C(3)-enolate activation modes: definition; general catalytic cycle; various intra- and intermolecular functionalisation reactions; curly arrow pushing mechanisms.

Lecture 2: HOMO-Raising Organocatalysis

2ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 64: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Bifunctional Activation vs Steric ControlLecture 2: HOMO-Raising Organocatalysis

3

•  Towards the end of lecture 1 we discussed bifunctional enamine catalysis using naturally occurring proline as the organocatalyst

•  However, bifunctional activation is not absolutely required for selective catalysis.

•  Other secondary amine organocatalysts rely on steric control.

B.Listetal.,Chem.Rev.,2007,107,5471.

•  In the following slides we will discuss the synthesis and reactivity of these important alternative secondary amine organocatalysts.

Proline BifunctionalActivation

RX Y H

N

OO

R1

H

NH

CO2HN

NH

MeO

Ph Me

MeMe N

H OTMS

PhPh

Steric Control

Page 65: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Imidazolidinone OrganocatalystsLecture 2: HOMO-Raising Organocatalysis

4

•  Imidazolidinone organocatalysts were introduced by MacMillan in 2000. They can be easily accessed in a short sequence from commercially available amino acids.

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2000,122,4243.

•  These catalysts control enamine geometry and shield one face of the enamine in order to control the stereochemical outcome of reactions. Control of both is crucial!

Bn

NH2

i) SOCl2, MeOH

Yb(OTf)3 (10 mol%) CHCl3

O

OHBn

NH2

NHMe

ON

NH

MeO

Bn t-Buii) MeNH2EtOH, rt, 48 h

Pivaldehyde

•  Let’s look at some specific examples.

N

NH

MeO

Bn t-BuH

O

Me

+-H2O

N

N

MeO

Ph Me

MeMe

Me

N

N

MeO

Ph Me

MeMe

Mereactive enamine

enamine Si-face exposed

Page 66: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective α-Chlorination of AldehydesLecture 2: HOMO-Raising Organocatalysis

5

•  Imidazolidinone organocatalysts have been employed for the enantioselective α-chlorination of aldehydes.

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2004,126,4108

•  For this class of organocatalytic reaction we must be able to:

1)  Identify how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  Rationalise the stereochemical outcome of the reaction (only enantiocontrol is relevant in this case) by drawing an appropriate transition state.

(5 mol%)AcetoneH

O

H

On-Hex 93% yield

92% e.e.+

Cl

O

ClCl

ClCl

Cl

Cl

N

NH

MeO

Bn MeMe

n-Hex

Page 67: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective α-Chlorination of AldehydesLecture 2: HOMO-Raising Organocatalysis

6

•  First let’s consider the organocatalytic activation mode:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2004,126,4108

•  We have the following information:

1)  A secondary amine Lewis base organocatalyst is used

2)  One reactant contains a aldehyde functional group and the other is a source of Cl+.

3)  The aldehyde is enolisable (e.g. it has α-hydrogen atoms that can be deprotonated)

•  Conclusion – this reaction proceeds via the enamine activation mode.

(5 mol%)AcetoneH

O

H

On-Hex 93% yield

92% e.e.+

Cl

O

ClCl

ClCl

Cl

Cl

N

NH

MeO

Bn MeMe

n-Hex

Page 68: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective α-Chlorination of AldehydesLecture 2: HOMO-Raising Organocatalysis

7

•  Let’s think about the key nucleophilic enamine species formed in detail:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2004,126,4108

•  The (E)-configuration is favoured over the (Z)-configuration due to steric congestion involving the hexyl substituent. One (E)-conformation is also favoured over the other

-H2O

(E)-enamine(E)-enamine (Z)-enamine (Z)-enamine

2 possible configurationseach with 2 conformations

H

On-Hex

N

NH

MeO

Bn MeMe

N

N

MeO

Bn MeMe

Hn-Hex

H

N

N

MeO

Bn MeMe

Hn-Hex

H

N

N

MeO

Bn MeMe

Hn-Hex

H

N

N

MeO

Bn MeMe

HH

n-Hex

Page 69: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective α-Chlorination of AldehydesLecture 2: HOMO-Raising Organocatalysis

8

•  Now let’s consider the curly arrow pushing mechanism:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2004,126,4108

•  The thermodynamic driving force for this reaction is the formation of an aromatic byproduct, derived from the ortho quinone chlorinating agent.

- H2O + H2O

(5 mol%)AcetoneH

O

H

On-Hex 93% yield

92% e.e.+

Cl

O

ClCl

ClCl

Cl

Cl

N

NH

MeO

Bn MeMe

n-Hex

N

N

MeO

Bn MeMe

n-Hex

O

ClCl

ClCl

Cl

ClN

N

MeO

Bn MeMe

n-Hex

ClH

OCl

ClCl

Cl

Cl

Page 70: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective α-Chlorination of AldehydesLecture 2: HOMO-Raising Organocatalysis

9

•  Finally, let’s rationalise the stereochemical outcome of the reaction:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2004,126,4108

•  Conformation such that the benzyl group blocks the Re-face of the enamine. Hence the electrophile approaches the Si-face of the enamine, giving enantioselectivity.

redraw

Reaction

Reaction

redraw

(S)

(S)

N

N

MeO

Bn MeMe

n-Hex

O

ClCl

ClCl

Cl

Cl

NN MeO

Me Me

n-HexH

Ph

enamine Si-face exposed"Cl"

On-HexH

Cl

H

On-Hex

Cl

+

(after hydrolysis)

Page 71: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective α-Fluorination of AldehydesLecture 2: HOMO-Raising Organocatalysis

10

•  Imidazolidinone catalysts also catalyse the α-fluorination of aldehydes:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2005,127,8826.

•  Conformation such that the benzyl group blocks the Re-face of the enamine. In some cases, the aldehyde products are reduced to the alcohols. Why?

(20 mol%)THFH

O

H

OCy α-fluoro aldehyde

96% yield99% e.e.

+

F

(S)Reaction

(S)

(after hydrolysis)

PhO2SNF

SO2Ph

N

NH

MeO

Bn MeMe

Cy

NN MeO

Me Me

CyH

Ph

enamine Si-face exposed"F"

OCyH

F

Page 72: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Diarylprolinol Silyl Ether OrganocatalystsLecture 2: HOMO-Raising Organocatalysis

11

•  Diarylprolinol silyl ether organocatalysts were introduced by Jørgensen and Hayashi in 2005. They are readily accessed in a short sequence from proline.

K.A.Jørgensenetal.,Angew.Chem.Int.Ed.,2005,44,794;Y.Hayashietal.,Angew.Chem.Int.Ed.,2005,44,4212.

•  These catalysts also control enamine geometry and shield one face of the enamine in order to control the stereochemical outcome of reactions.

i) Boc2O, NaHCO3 THF

ii) MeI, K2CO3 DMF

NH

CO2H NBoc

CO2Me

i) PhMgBr, THFii) NaOH, EtOH

iii) TMSOTf, Et3NCH2Cl2

NH

PhPh

OTMS

•  Let’s look at some specific examples.

H

O

Me

+-H2O

reactive enamine

enamine Si-face exposed

NH

PhPh

OTMSN

PhPh

OTMS

Me

N

PhPh

OTMS

Me

Page 73: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Michael Addition of AldehydesLecture 2: HOMO-Raising Organocatalysis

12

•  Diarylprolinol silyl ether organocatalysts have been employed for the enantioselective Michael addition of aldehydes to methylvinyl ketone.

K.A.Jørgensenetal.,J.Am.Chem.Soc.,2005,127,18296

•  For this class of organocatalytic reaction we must be able to:

1)  Identify how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  Rationalise the stereochemical outcome of the reaction (only enantiocontrol is relevant in this case) by drawing an appropriate transition state.

EtOHH

O

H

O83% yield93% e.e.

+

Et

EtMe

O

NH

ArAr

OTMSAr = (3,5-CF3)C6H3

(10 mol%)

Me

O

Page 74: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Michael Addition of AldehydesLecture 2: HOMO-Raising Organocatalysis

13

•  First let’s consider the organocatalytic activation mode:

K.A.Jørgensenetal.,J.Am.Chem.Soc.,2005,127,18296

•  We have the following information:

1)  A secondary amine Lewis base organocatalyst is used

2)  One reactant contains an aldehyde functional group and the other is an enone.

3)  The aldehyde and enone are enolisable (e.g. they both have α-hydrogen atoms that can be deprotonated)

•  Conclusion – this reaction proceeds via the enamine activation mode.

EtOHH

O

H

O83% yield93% e.e.

+

Et

EtMe

O

NH

ArAr

OTMSAr = (3,5-CF3)C6H3

(10 mol%)

Me

O

Page 75: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Michael Addition of AldehydesLecture 2: HOMO-Raising Organocatalysis

14

•  Let’s think about the key nucleophilic enamine species formed in detail:

K.A.Jørgensenetal.,J.Am.Chem.Soc.,2005,127,18296

•  The (E)-configuration is favoured over the (Z)-configuration due to steric congestion involving the ethyl substituent. One (E)-conformation is also favoured over the other

-H2O

(E)-enamine(E)-enamine (Z)-enamine (Z)-enamine

2 possible configurationseach with 2 conformations

H

OEt

NH

ArAr

OTMS

N

ArAr

OTMSH

Et

HN

ArAr

OTMS

HEt

HN

ArAr

OTMSH

H

Et

HH

N

ArAr

OTMS

HH

Et

Page 76: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Michael Addition of AldehydesLecture 2: HOMO-Raising Organocatalysis

15

•  Now let’s consider the curly arrow pushing mechanism:

K.A.Jørgensenetal.,J.Am.Chem.Soc.,2005,127,18296

•  An enamine could also be formed with the enone starting material, but the aldehyde is considerably more electrophilic that then carbonyl within the enone. Why?

- H2O + H2O

EtOHH

O

H

O83% yield93% e.e.

+

Et

EtMe

O

NH

ArAr

OTMSAr = (3,5-CF3)C6H3

(10 mol%)

Me

O

N

ArAr

OTMS

Et

Me

ON

ArAr

OTMS

EtMe

O

H

Page 77: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Michael Addition of AldehydesLecture 2: HOMO-Raising Organocatalysis

16

•  Finally, let’s rationalise the stereochemical outcome of the reaction:

K.A.Jørgensenetal.,J.Am.Chem.Soc.,2005,127,18296

•  Conformation such that the large group blocks the Re-face of the enamine. Hence the electrophile approaches the Si-face of the enamine, giving enantioselectivity.

redraw

Reaction

Reaction

redraw

(R)

N

ArAr

OTMS

Et

Me

O

NEtH

enamine Si-face exposed

TMSO ArAr

MeO

OEtH

MeO

H

O

EtMe

O(R)

+

(after hydrolysis)

Page 78: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective α-Sulfination of Aldehydes – Class ExampleLecture 2: HOMO-Raising Organocatalysis

17

•  Diarylprolinol silyl ether organocatalysts also promote the α-sulfination of aldehydes. Determine the major product for the reaction shown below:

K.A.Jørgensenetal.,J.Am.Chem.Soc.,2005,127,18296

•  The triazole on sulfur is a good leaving group (pKa = 10.3) which makes the sulfur compound a good electrophile, susceptible to nucleophilic attack the the enamine.

(10 mol%)TolueneH

O+

BnS

Et N

N

N

NH

PhPh

OTMS

Page 79: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Dienamine Activation ModeLecture 2: HOMO-Raising Organocatalysis

18

•  K. A. Jørgensen has explored extending the conjugated system by employing enolisable α,β-unsaturated aldehydes as substrates:

K.A.Jørgensenetal.,J.Am.Chem.Soc.,2006,128,12973

•  It was unknown if these dienamine species would react with electrophiles at the α-position (as with normal enamines) or at the γ-position.

H

ON

ArAr

OTMS

R-H2O

R

HH

Deprotonation canoccur at γ−position

γβ

α

-H+

N

ArAr

OTMS

RNucleophilic dienamine

Page 80: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

γ-Amination of EnalsLecture 2: HOMO-Raising Organocatalysis

18

•  Interestingly it was found the the dienamines react selectively at the at the γ-position, but give the opposite enantioselectivity to what was expected when employed in a γ-amination process.

K.A.Jørgensenetal.,J.Am.Chem.Soc.,2006,128,12973

•  Computation studies revealed that reaction at the γ-position was favoured (lowed in energy), explaining the observed regiochemical outcome.

•  However, further studies were needed to rationalise the stereochemical outcome.

expected product(not observed)

N

ArAr

OTMS

R

E

E

20.9 kcal/mol

13.0 kcal/mol

O

R

N

unexpected product

NN

CO2Et

EtO2C

EtO2C

NHEtO2C

O

R

NEtO2C

NHEtO2C

(After Hydrolysis)

Page 81: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

γ-Amination of EnalsLecture 2: HOMO-Raising Organocatalysis

20

•  The conformation of the dienamine species is critical is this process:

K.A.Jørgensenetal.,J.Am.Chem.Soc.,2006,128,12973

•  The (E,s-trans,E) conformation is lower in energy, with rotation around the C-C bond giving rise to the higher energy (E,s-cis,E) conformation.

•  The (E,s-cis,E) conformation can react with the diethyl azocarboxylate in a formal [4+2] cycloaddition process that is very energetically favoured.

•  This is the most energetically favoured pathway to product formation.

N

ArAr

OTMS

R(E,s-trans,E)0 kcal/mol

rotationN

ArAr

OTMS

(E,s-cis,E)7.5 kcal/mol

RNN

CO2Et

EtO2C

N

ArAr

OTMS

R

NN

CO2EtCO2Et

-23.5 kcal/mol

H2OO

R

NCO2Et

HNCO2Et

(R)

Page 82: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

γ-Amination of EnalsLecture 2: HOMO-Raising Organocatalysis

21

•  Diarylprolinol silyl ether organocatalysts promote the γ-amination of enals:

K.A.Jørgensenetal.,J.Am.Chem.Soc.,2006,128,12973

•  The large group blocks the top face of the dienamine, giving rise to a highly enantio-selective process. This is another example of steric control.

TolueneH

O

NN

CO2Et

γ-amino enal56% yield89% e.e.+

EtO2C

Reaction

(after hydrolysis)

NH

ArAr

OTMSAr = (3,5-CF3)C6H3

(10 mol%)

Me

H

O

Me

NHN

CO2Et

CO2Et

NN CO2Et

EtO2C

N

Ar ArOTMS

MeN

HN CO2Et

EtO2C

O

Me(R)

(R)

blocks top face

Page 83: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enamine Organocatalysis Cheat SheetLecture 2: HOMO-Raising Organocatalysis

22

•  For enamine organocatalysis, you must remember the following key information:

•  The enamine activation mode requires primary or secondary amine organocatalysts and enolisable aldehyde or ketone substrates.

B.Listetal.,Chem.Rev.,2007,107,5471.

NH

CO2HN

NH

MeO

Ph Me

MeMe

NH OTMS

PhPh + many others!

•  In order to rationalise the stereochemistry of reactions involving enamines you must:

1) Identifying whether the catalyst operates by bifunctional activation (via hydrogen bonding) or steric control.

2) Carefully consider the possible configurations (e.g. E vs Z) and conformations (e.g. s-cis vs s-trans) of the key enamine intermediate.

3) Draw a suitable 3D-representation of the transition state.

Page 84: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

An Overview of OrganocatalysisLecture 2: HOMO-Raising Organocatalysis

23ForanexcellentoverviewseeD.Romoetal.,Nat.Prod.Rep.,2014,31,1318.

•  Organocatalysis is now a thoroughly established member of the synthetic toolbox, with a large number of generic activation modes known.

Covalent Activation Modes Non-Covalent Activation Modes

R2

N

Enamine (di-, tri-, tetra-enamine) Catalysis

R2

N

Iminium Catalysis

R1 R2

O

Phosphine Catalysis

R1

P

Cat

O

C(1)-Enolate (di-enolate)Catalysis

Cat

O

Acyl ammonium/azoliumCatalysis

R1

R1

R1

OH

N-Heterocyclic Carbene Catalysis

R1

RN

RN

CatO

R1

C(2)-EnolateCatalysis

O

R1

C(3)-EnolateCatalysis

Cat R2

N

SOMO CatalysisR1

R1 R2

XR2

HO

PO

Brønsted AcidCatalysis

R1 R2

XR

Phase-transferCatalysis

NR4

R1 R2

XR2

OP

O

Chiral AnionCatalysis

R1 R2

X

Hydrogen BondingCatalysis

H HRN NR

S

•  Let’s now focus on HOMO-raising organocatalysis beyond enamine activation.

Page 85: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Classes of OrganocatalystLecture 2: HOMO-Raising Organocatalysis

24ForanoverviewseeD.W.C.MacMillan,Nature,2008,455,304.

•  Let’s start with an overview of the classes of organocatalyst. We have already covered secondary amines in detail during lectures 1 and 2:

NH

CO2HN

NH

MeO

Ph Me

MeMe

NH OTMS

PhPh

•  There are three more important classes of Lewis base organocatalyst that we need to know for the remainder of this lecture:

1)  Tertiary amines

2)  N-heterocyclic carbenes

3)  Phosphines

•  Each is able to activate a substrate by donating a lone pair of electrons (Lewis base) catalysts.

Page 86: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Tertiary Amine OrganocatalystsLecture 2: HOMO-Raising Organocatalysis

25M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  Tertiary amines have found utility across a wide range of organocatalytic processes.

•  Achiral examples:

N N

NMe2

N NN

N

N

N

N

pyridine DMAP quinuclidine DABCO DBN DBU

•  Chiral examples:

N

OMe

N

OHN

SNPh

i-PrFeMe

MeMe

Me

MeN

N

Planar-chiral DMAP derivatives

Cinchona alkaloids(quinidine)

Isothioureas

Page 87: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

N-Heterocyclic Carbene OrganocatalystsLecture 2: HOMO-Raising Organocatalysis

26T.Rovisetal.,Chem.Rev.,2015,115,9307.

•  N-heterocyclic carbenes (NHCs) have become increasingly popular organocatalysts

•  Achiral examples:

•  Chiral examples:

NN RR NS R

MeHO

Imidazole-based Triazole-basedThiazole-based

NNN R

NEt2Et2N

Bis(amino)cyclopropenyl-based

NN BnBn

NNN R1

R2

NNN R

O

C(2)-symmetricimidazole-based Chiral triazole-based (most common)

Page 88: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Phosphine OrganocatalystsLecture 2: HOMO-Raising Organocatalysis

27W.R.Roushetal.,Adv.Synth.Catal..,2004,346,1035.

•  Phosphines demonstrate some unique organocatalytic reactivity.

•  Achiral examples:

•  Chiral examples:

BuPBu

BuTrialkylphosphines

ArPAr

ArTriarylphosphines

R2

R1

P R2 P PhP P

Axially chiral phosphines

Page 89: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

HOMO-Raising Catalysis Beyond Enamine ActivationLecture 2: HOMO-Raising Organocatalysis

28B.Listetal.,Chem.Rev.,2007,107,5471.

•  So far we have discussed enamine organocatalysis as a method of α-functionalisation of carbonyl compounds:

•  The enamine activation mode has the following key characteristics:

1)  It is a covalent activation mode – the catalyst is covalently bound to the substrate.

2)  It is a nucleophilic (HOMO-raised) activation mode – it reacts with electrophiles.

3)  It employs primary and secondary amine Lewis base organocatalysts and enolisable aldehyde/ketone substrates.

R1R3

N

R2

E

Enamine Organocatalysis

Page 90: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

HOMO-Raising Catalysis Beyond Enamine ActivationLecture 2: HOMO-Raising Organocatalysis

29M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  Enamine catalysis is extremely powerful, but it is primarily limited to aldehyde and ketone substrates and does not extend to esters, amides etc.

•  There is an alternative way to generate chiral ester enolate equivalents, known as enolate organocatalysis.

Enolate Organocatalysis

R1LB

O

R2

E

H

O

R

N

NH

MeO

Bn MeMe

N

N

MeO

Bn MeMe

R

X

O

R

N

NH

MeO

Bn MeMe

N

N

MeO

Bn MeMe

RX = OR, NR2

no condensation X

Page 91: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

HOMO-Raising Catalysis Beyond Enamine ActivationLecture 2: HOMO-Raising Organocatalysis

30M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  Enolate organocatalysis is split into three sub-classes 3-subclasses:

•  A wide variety of Lewis base organocatalysts can be used to generate these species:

C(1)-Enolate

RLB

O

1

C(2)-Enolate

LBR

O

12

C(3)-EnolateR

O

12

LB 3

N

OMe

N

OHNNN Ph

O

P Ph

Tertiary Amines N-Heterocyclic Carbenes Phosphines

•  We will consider the chemistry of each class of enolate in this lecture

Page 92: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Enolate Organocatalytic Activation ModeLecture 2: HOMO-Raising Organocatalysis

31M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  C(1)-enolates are widely employed as chiral ester enolate equivalents:

•  The C(1)-enolate activation mode has the following key characteristics:

1)  It is a covalent activation mode – the catalyst is covalently bound to the substrate.

2)  It is a nucleophilic (HOMO-raised) activation mode – it reacts with electrophiles.

3)  It employs tertiary amine, phosphine and N-heterocyclic carbene Lewis base organocatalysts

4)  It can be accessed from a wide variety of electrophilic substrates including ketenes, acid chlorides, carboxylic esters/acids etc.

C(1)-Enolate Activation Mode

R1LB

O

R2

E1

Page 93: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Ketenes as Precursors for C(1)-EnolatesLecture 2: HOMO-Raising Organocatalysis

32M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  C(1)-enolates can be accessed from ketene precursors:

•  Once generated, the C(1)-enolate can react with a variety of electrophiles at the α-position.

•  Subsequent nucleophilic attack by an internal or external nucleophile accesses the product with regeneration of the catalyst.

•  When the nucleophile is an alcohol or amine, this process amounts to a formal α-functionalisation of esters or amides.

R1LB

O

1

O

R1

LB R1LB

O

E

Nuc-H

HH

* R1Nuc

O

E

Ketene C(1)-Enolate

*

Page 94: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Enolate Organocatalysis – General MechanismLecture 2: HOMO-Raising Organocatalysis

33

•  We can draw the following catalytic cycle for C(1)-enolate organocatalysis:

M.Gauntet.al.,Chem.Rev.,2007,107,5596.

•  Remember that a variety of other substrates can serve as C(1)-enolate precursors.E

Lewis baseorganocatalyst

C(1)-Enolate

LB

O

R1 H

Ketene

R1LB

O

1

H

R1LB

O

E

*

Nuc-H

R1Nuc

O

E

*

Page 95: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Enolate Organocatalysis – PrecursorsLecture 2: HOMO-Raising Organocatalysis

34

•  A variety of electrophilic precursors can be used to access C(1)-enolates:

M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  Let’s look at some specific examples.

R1Cl

O

OR2

R1

R1O

O

2R1

OH

O

LB

Ketenes Acid Chlorides AnhydridesCarboxylic

Acids

R1OR

O

Esters

C(1)-Enolate Activation Mode

R1LB

O

R2

E1

basebase base base

Page 96: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

35

•  Fu employed planar-chiral DMAP derivatives for enantioselective β-lactam synthesis:

G.Fuetal.,J.Am.Chem.Soc.,2002,124,1578

•  For this class of organocatalytic reaction we must be able to:1)  Identify how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  To rationalise the stereochemical outcome of the reaction is beyond the scope of this course.

(5 mol%)

THF

β-lactam97% yield80% d.e.95% e.e.

O

Ph Et

+N

H

FeMe

MeMe

Me

MeN

N

TsNO

EtPhO

Ts

O

Page 97: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

36

•  First let’s consider the organocatalytic activation mode:

G.Fuetal.,J.Am.Chem.Soc.,2002,124,1578

•  We have the following information:

1)  A tertiary amine Lewis base organocatalyst is used

2)  One reactant is a ketene and the other contains an imine functional group.

•  This reaction proceeds via the C(1)-ammonium enolate activation mode.

(5 mol%)

THF

β-lactam97% yield80% d.e.95% e.e.

O

Ph Et

+N

H

FeMe

MeMe

Me

MeN

N

TsNO

EtPhO

Ts

O

Page 98: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

37

•  Now let’s consider the curly arrow pushing mechanism:

G.Fuetal.,J.Am.Chem.Soc.,2002,124,1578

•  You will not be expected to explain the diastereo- or enantioselectivity of this process.

(5 mol%)

THF

β-lactam97% yield80% d.e.95% e.e.

O

Ph Et

+N

H

FeMe

MeMe

Me

MeN

N

TsNO

EtPhO

Ts

O

PhR3N

O

Et

N

HO

Ts

PhR3N

O

Et

NTs

O

Page 99: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

38

•  Carboxylic acids are also useful C(1)-ammonium enolate precursors:

D.Romoetal.,J.Am.Chem.Soc.,2012,134,13348

•  For this class of organocatalytic reaction we must be able to:

1)  Know how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  To rationalise the stereochemical outcome of the reaction is beyond the scope of this course.

β-lactone65% yield>90% d.e.99% e.e.

O

OMe

CO2Hi) p-TsCl, i-PrNEt2

ii)

N

N

SPh(20 mol%)

i-PrNEt2, THF

O

O Me

O

Page 100: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

39

•  First let’s consider the organocatalytic activation mode:

D.Romoetal.,J.Am.Chem.Soc.,2012,134,13348

•  We have the following information:

1)  A tertiary amine Lewis base organocatalyst is used

2)  The substrate contains a carboxylic acid and two ketone functional groups. The first step of the reaction is to activate the carboxylic acid.

•  This reaction proceeds via the C(1)-ammonium enolate activation mode.

β-lactone65% yield>90% d.e.99% e.e.

O

OMe

CO2Hi) p-TsCl, i-PrNEt2

ii)

N

N

SPh(20 mol%)

i-PrNEt2, THF

O

O Me

O

Page 101: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

40

•  Now let’s consider the curly arrow pushing mechanism:

D.Romoetal.,J.Am.Chem.Soc.,2012,134,13348

•  You should be able to draw a curly arrow pushing mechanism for the activation step also but are not expected to rationalise the stereochemical outcome.

β-lactone65% yield>90% d.e.99% e.e.

O

OMe

CO2Hi) p-TsCl, i-PrNEt2

ii)

N

N

SPh(20 mol%)

i-PrNEt2, THF

O

O Me

O

Page 102: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Application Towards Natural Product SynthesisLecture 2: HOMO-Raising Organocatalysis

41

•  Romo elaborated this product to (-)-cucumalacatone and (-)-curcimanolide A over 9 and 8 steps respectively:

D.Romoetal.,J.Am.Chem.Soc.,2012,134,13348

O

O Me

O

β-lactone>90% d.e.99% e.e.

8 Steps 9 Steps

(−)-curcumanolide A

Me

MeO

Me Me

O

(−)-curcumalactone

Me

MeO

Me Me

O

Page 103: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Azolium EnolatesLecture 2: HOMO-Raising Organocatalysis

42

•  Chi has reported the use of N-heterocyclic carbenes for activation of carboxylate esters:

Y.R.Chietal.,Org.Lett.,2012,14,2154

•  For this class of organocatalytic reaction we must be able to:

1)  Know how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  To rationalise the stereochemical outcome of the reaction is beyond the scope of this course.

(30 mol%)

i-PrNEt2, CH2Cl2

dihydropyridone89% yield>90% d.e.92% e.e.

+PhOAr

O

Ar = 4-NO2C6H4

Ph Ph

NTs

NNN R

Bn

BF4

NTsPh

Ph

O

Ph

Page 104: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Azolium EnolatesLecture 2: HOMO-Raising Organocatalysis

43

•  First let’s consider the organocatalytic activation mode:

Y.R.Chietal.,Org.Lett.,2012,14,2154

•  We have the following information:

1)  A N-heterocyclic carbene Lewis base organocatalyst is used

2)  One reactant is a carboxylic ester and the other contains an α,β-unsaturated imine functional group.

•  This reaction proceeds via the C(1)-azolium enolate activation mode.

(30 mol%)

i-PrNEt2, CH2Cl2

dihydropyridone89% yield>90% d.e.92% e.e.

+PhOAr

O

Ar = 4-NO2C6H4

Ph Ph

NTs

NNN R

Bn

BF4

NTsPh

Ph

O

Ph

Page 105: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(1)-Azolium EnolatesLecture 2: HOMO-Raising Organocatalysis

44

•  Now let’s consider the curly arrow pushing mechanism:

Y.R.Chietal.,Org.Lett.,2012,14,2154

•  You will not be expected to explain the diastereo- or enantioselectivity of this process.

(30 mol%)

i-PrNEt2, CH2Cl2

dihydropyridone89% yield>90% d.e.92% e.e.

+PhOAr

O

Ar = 4-NO2C6H4

Ph Ph

NTs

NNN R

Bn

BF4

NTsPh

Ph

O

Ph

PhLB

O

Ph Ph

NTsLB

Ph

Ph

O

NTsPh

Page 106: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(2)-Enolate Organocatalytic Activation ModeLecture 2: HOMO-Raising Organocatalysis

45M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  C(2)-enolates are also employed as chiral nucleophilic intermediates:

•  The C(2)-enolate activation mode has the following key characteristics:

1)  It is a covalent activation mode – the catalyst is covalently bound to the substrate.

2)  It is a nucleophilic (HOMO-raised) activation mode – it reacts with electrophiles.

3)  It employs mainly tertiary amine Lewis base organocatalysts

4)  It is commonly accessed from α-halo carbonyl compounds.

C(2)-Enolate Activation Mode

E1

LBR

O

2

Page 107: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Precursors for C(2)-EnolatesLecture 2: HOMO-Raising Organocatalysis

46M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  C(2)-enolates are commonly accessed from α-halo carbonyl compounds:

•  Once generated, the C(2)-enolate can react with a variety of electrophiles at the α-position.

•  Subsequent nucleophilic attack by an internal or external nucleophile accesses the product with regeneration of the catalyst.

•  When an internal nucleophile is used, this results in ring-forming reactions.

LB LBR

O

E

Nuc-H* Nuc

R

O

EC(2)-Enolate

*XR

O

X = Br, Cl, I, OTs

LBR

O

12

Ebase

Page 108: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(2)-Enolate Organocatalysis – General MechanismLecture 2: HOMO-Raising Organocatalysis

47

•  We can draw the following catalytic cycle for C(2)-enolate organocatalysis:

M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  Let’s consider a specific example.

E

Lewis baseorganocatalyst

C(2)-Enolate

LB

Nuc-H

XR

O

LBR

O

12

LBR

O

E

*

NucR

O

E

*

base

Page 109: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(2)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

48

•  Gaunt employed cinchona alkaloid-derived organocatalysts for enantioselective cyclopropanation

M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  For this class of organocatalytic reaction we must be able to:1)  Know how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  To rationalise the stereochemical outcome of the reaction is beyond the scope of this course.

(10 mol%), Cs2CO3

MeCN

cyclopropane96% yield>90% d.e.86% e.e.

+t-BuO

OBr

Ph

ON

OMe

N

OMe

t-BuO

OPh

O

Page 110: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(2)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

49

•  First let’s consider the organocatalytic activation mode:

M.Gauntetal.,Angew.Chem.Int.Ed.,2004,43,4641

•  We have the following information:

1)  A tertiary amine Lewis base organocatalyst is used

2)  One reactant is an α-halo carbonyl compound and the other is an enone.

•  This reaction proceeds via the C(2)-ammonium enolate activation mode.

(10 mol%), Cs2CO3

MeCN

cyclopropane96% yield>90% d.e.86% e.e.

+t-BuO

OBr

Ph

ON

OMe

N

OMe

t-BuO

OPh

O

Page 111: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(2)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

50

•  Now let’s consider the curly arrow pushing mechanism:

M.Gauntetal.,Angew.Chem.Int.Ed.,2004,43,4641

•  You will not be expected to explain the diastereo- or enantioselectivity of this process.

(10 mol%), Cs2CO3

MeCN

cyclopropane96% yield>90% d.e.86% e.e.

+t-BuO

OBr

Ph

ON

OMe

N

OMe

t-BuO

OPh

O

Ph

OLB

t-BuO

OLB

t-BuO

O

OPh

Page 112: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(3)-Enolate Organocatalytic Activation ModeLecture 2: HOMO-Raising Organocatalysis

51M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  C(3)-enolates are also employed as chiral nucleophilic intermediates:

•  The C(3)-enolate activation mode has the following key characteristics:

1)  It is a covalent activation mode – the catalyst is covalently bound to the substrate.

2)  It is a nucleophilic (HOMO-raised) activation mode – it reacts with electrophiles.

3)  It employs mainly tertiary amine and phosphine Lewis base organocatalysts

4)  It is commonly accessed from α,β-unsaturated carbonyl compounds.

C(3)-Enolate Activation Mode

E

12

R

O

LB 3

Page 113: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Precursors for C(3)-EnolatesLecture 2: HOMO-Raising Organocatalysis

52M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  C(3)-enolates are commonly accessed from α,β-unsaturated carbonyl compounds:

•  Once generated, the C(3)-enolate can react with a variety of electrophiles at the α-position.

•  Subsequent elimination accesses the product with regeneration of the catalyst.

•  The most common reaction of C(3)-enolates is with aldehydes or imine – the (aza)-Morita-Baylis-Hillman reaction.

LBR

O

ER

O

ER

O

R = Me, Ph, ORR

O

LBC(3)-Enolate

LBBase

*

Page 114: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(3)-Enolate Organocatalysis – General MechanismLecture 2: HOMO-Raising Organocatalysis

53

•  We can draw the following catalytic cycle for C(3)-enolate organocatalysis:

M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  Let’s consider a specific example.E

Lewis baseorganocatalyst

LB

Base

R

O

R

O

LBC(3)-Enolate

12

3R

O

ELB *

R

O

E

Page 115: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(3)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

54

•  Hatakeyama employed the cinchona alkaloid-derived organocatalyst, β-isocupreidine, for the enantioselective Morita-Baylis-Hillman reaction.

S.Hatakeyamaetal.,J.Am.Chem.Soc.,1999,121,10219.

•  For this class organocatalytic reaction we must be able to:1)  Know how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  To rationalise the stereochemical outcome of the reaction is beyond the scope of this course.

(10 mol%)

DMF

MBH adduct57% yield95% e.e.

+H Ph

ON

OH

N

O

Et

O

O

CF3

CF3

O

O

CF3

CF3

OHPh

Page 116: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(3)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

55

•  First let’s consider the organocatalytic activation mode:

S.Hatakeyamaetal.,J.Am.Chem.Soc.,1999,121,10219.

•  We have the following information:

1)  A tertiary amine Lewis base organocatalyst is used

2)  One reactant is an α,β-unsaturated carbonyl compound, the other is an aldehyde.

•  This reaction proceeds via the C(3)-ammonium enolate activation mode.

(10 mol%)

DMF

MBH adduct57% yield95% e.e.

+H Ph

ON

OH

N

O

Et

O

O

CF3

CF3

O

O

CF3

CF3

OHPh

Page 117: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

C(3)-Ammonium EnolatesLecture 2: HOMO-Raising Organocatalysis

56

•  Now let’s consider the curly arrow pushing mechanism:

S.Hatakeyamaetal.,J.Am.Chem.Soc.,1999,121,10219.

•  You will not be expected to explain the enantioselectivity of this process.

(10 mol%)

DMF

MBH adduct57% yield95% e.e.

+H Ph

ON

OH

N

O

Et

O

O

CF3

CF3

O

O

CF3

CF3

OHPh

OR

O

LB H Ph

O

OR

O

LB

OPh

Proton TransfersCatalyst Elimination

Page 118: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enolate Organocatalysis Cheat SheetLecture 2: HOMO-Raising Organocatalysis

57

•  For enolate organocatalysis, you must remember the following key information:

•  C(1)-, C(2)- and C(3)-enolates are typically accessed using tertiary amines, N-heterocyclic carbenes and phosphines.

M.Gauntetal.,Chem.Rev.,2007,107,5596.

•  C(1)-, C(2)- and C(3)-enolates are generated from ketenes (and others), α-halo carbonyl compounds and α,β-unsaturated carbonyl compounds respectively.

•  You will be expected to be able to identify the specific organocatalytic activation mode involved in a given reaction and provide a curly arrow pushing mechanism.

•  Rationalising the stereochemical outcome of reactions involving organocatalytic enolates is beyond the scope of this course.

NNN R1

R2

N

SNPh

i-PrP Ph

Page 119: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Key learning objectives:

•  The enamine organocatalytic activation mode (part 2): Bifunctional vs. steric control; synthesis and reactivity of imidazolidinone and diarylprolinol silyl ether organocatalysts.

•  Dienamine organocatalytic activation mode.

•  Alternative HOMO-raising organocatalytic activation modes.

•  C(1)-, C(2)- and C(3)-enolate activation modes: definition; general catalytic cycle; various intra- and intermolecular functionalisation reactions; curly arrow pushing mechanisms.

Lecture 2: HOMO-Raising Organocatalysis

58ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 120: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

To reinforce your understanding of the contents of this lecture, please refer to:

•  Organic Chemistry 2nd Ed. (J. Clayden, N. Greeves and S. Warren, Oxford University Press, 2012, ISBN 978-0-19-927029-3). Chapter 41 is particularly relevant.

•  New Frontiers in Asymmetric Catalysis (K. Mikami and M. Lautens, Wiley, 2007). Downloadable from University Network. DOI: 10.1002/0470098007

•  Catalytic Asymmetric Synthesis 3rd Ed. (I. Okima, Wiley, 2010). Downloadable from University Network. DOI: 10.1002/9780470584248

•  Prof. MacMillan Short-Course: www.princeton.edu/chemistry/macmillan/research/

•  Leading review articles on enamine catalysis (Chem. Rev., 2007, 107, 5471) and enolate catalysis (Chem. Rev., 2007, 107, 5596).

•  CH3404 Feedback Workshop

Lecture 2 Revision

59ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 121: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Dr Louis C. MorrillSchool of Chemistry, Cardiff University

Main Building, Rm [email protected]

CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural Products

LCM Lecture 3

1ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 122: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Key learning objectives:

•  Traditional LUMO lowering of carbonyl compounds using Lewis acids.

•  The iminium organocatalytic activation mode: definition; general catalytic cycle; various intra- and intermolecular functionalisation reactions; curly arrow pushing mechanisms; stereochemical rationale.

•  Iminium-enamine organocatalytic cascades.

•  Alternative LUMO-lowering organocatalytic activation modes.

•  Acyl cation organocatalytic activation mode: acyl ammonium/azolium intermediates; definition; general catalytic cycle; various intra- and intermolecular functionalisation reactions; curly arrow pushing mechanisms.

•  α,β-Unsaturated acyl ammonium/azolium activation modes: definition; general catalytic cycle; various intra- and intermolecular functionalisation reactions; curly arrow pushing mechanisms.

Lecture 3: LUMO-Lowering Organocatalysis

2ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 123: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

An Overview of OrganocatalysisLecture 3: LUMO-Lowering Organocatalysis

3ForanexcellentoverviewseeD.Romoetal.,Nat.Prod.Rep.,2014,31,1318.

•  Organocatalysis is now a thoroughly established member of the synthetic toolbox, with a large number of generic activation modes known.

Covalent Activation Modes Non-Covalent Activation Modes

R2

N

Enamine (di-, tri-, tetra-enamine) Catalysis

R2

N

Iminium Catalysis

R1 R2

O

Phosphine Catalysis

R1

P

Cat

O

C(1)-Enolate (di-enolate)Catalysis

Cat

O

Acyl ammonium/azoliumCatalysis

R1

R1

R1

OH

N-Heterocyclic Carbene Catalysis

R1

RN

RN

CatO

R1

C(2)-EnolateCatalysis

O

R1

C(3)-EnolateCatalysis

Cat R2

N

SOMO CatalysisR1

R1 R2

XR2

HO

PO

Brønsted AcidCatalysis

R1 R2

XR

Phase-transferCatalysis

NR4

R1 R2

XR2

OP

O

Chiral AnionCatalysis

R1 R2

X

Hydrogen BondingCatalysis

H HRN NR

S

•  Today we will focus on LUMO-lowering organocatalysis.

Page 124: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

LUMO-Lowering of Carbonyl CompoundsLecture 3: LUMO-Lowering Organocatalysis

4P.M.Pihkoetal.,Chem.Rev.,2007,107,5416.

•  Lewis acid catalysis typically involves the activation of a substrate towards nucleophilic attack by lowering the LUMO component of the electrophile with respect to the HOMO component of the nucleophile:

•  MacMillan postulated that amines could function as catalysts that traditionally employ Lewis acids:

O

R

LA O

R

LA

LUMOlowered

O

R

N

R

R1

LUMOlowered

NH

R1 R1

-H2O

R1

O

R

LA O

R

LAO

R

LA O

R

LAO

R- LA

LUMOlowered

Page 125: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Iminium OrganocatalysisLecture 3: LUMO-Lowering Organocatalysis

5P.M.Pihkoetal.,Chem.Rev.,2007,107,5416.

•  Let’s now focus on another important activation mode – iminium catalysis.

•  The iminium activation mode has the following key characteristics:

1)  It is a covalent activation mode – the catalyst is covalently bound to the substrate.

2)  It is an electrophilic (LUMO-lowered) activation mode – it reacts with nucleophiles.

3)  It employs primary and secondary amine Lewis base organocatalysts and α,β-unsaturated aldehyde/ketone substrates.

R4

N

Iminium Organocatalysis

R1

R3

R2

Nuc

Page 126: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Iminium Organocatalysis – General MechanismLecture 3: LUMO-Lowering Organocatalysis

6

•  We can imagine using a chiral secondary amine for asymmetric organocatalysis

P.M.Pihkoetal.,Chem.Rev.,2007,107,5416.

NH

N

R1

R1

O

H2OH2OAmine

IminiumIminium

R2

R2

NucN

R1

R2 Nuc*

N

R1

R2 Nuc*

H2O

O

R1

R2 Nuc*

Page 127: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Iminium OrganocatalysisLecture 3: LUMO-Lowering Organocatalysis

7

•  Let’s revisit the pioneering work of D. W. C. MacMillan who reported the first enantioselective organocatalytic Diels-Alder reaction in 2000:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2000,122,4243.

•  For this class of organocatalytic reaction we must be able to:

1)  Know how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  Rationalise the stereochemical outcome of the reaction (both diastereo- and enantiocontrol are relevant in this case) by drawing an appropriate transition state.

(20 mol%)

MeOH-H2O

O

H

N

NH Me

Me

MeO

Bn

CHO

cycloadduct82% yield88% d.e.94% e.e.

+

Page 128: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Organocatalytic Diels-Alder ReactionLecture 3: LUMO-Lowering Organocatalysis

8

•  First let’s consider the organocatalytic activation mode:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2000,122,4243.

•  We have the following information:

1)  A secondary amine Lewis base organocatalyst is used

2)  One substrate contains an aldehyde functional group, with the other being a diene

3)  The aldehyde is non-enolisable (e.g. it has no α- or γ-hydrogen atoms that can be readily deprotonated)

•  Conclusion – this reaction proceeds via the iminium activation mode.

(20 mol%)

MeOH-H2O

O

H

N

NH Me

Me

MeO

Bn

CHO

cycloadduct82% yield88% d.e.94% e.e.

+

Page 129: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Organocatalytic Diels-Alder ReactionLecture 3: LUMO-Lowering Organocatalysis

9

•  Let’s think about the key electrophilic iminium species formed in detail:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2000,122,4243

•  The (E)-configuration is favoured over the (Z)-configuration due to steric congestion involving the geminal methyl substituents. The E-s-trans conformation is favoured.

-H2O

(E,s-cis)-iminium(E,s-trans)-iminium (Z,s-trans)-iminium (Z,s-cis)-iminium

2 possible configurationseach with 2 conformations

O

H

N

NH Me

Me

MeO

Bn

N

N Me

Me

MeO

Bn

H

N

N Me

Me

MeO

Bn

H

N

N Me

Me

MeO

Bn

H

N

N Me

Me

MeO

Bn

HH

H

H

H

Page 130: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Organocatalytic Diels-Alder ReactionLecture 3: LUMO-Lowering Organocatalysis

10

•  Now let’s consider the curly arrow pushing mechanism:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2000,122,4243.

•  As always, we must draw the curly arrows for every step of the mechanisms (including iminium formation/hydrolysis).

- H2O

(20 mol%)

MeOH-H2O

N

NH Me

Me

MeO

Bn

CHO

cycloadduct82% yield88% d.e.94% e.e.

N

N Me

Me

MeO

Bn

H

N

N Me

Me

MeO

Bn

H

- H2O

O

H+

Page 131: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Organocatalytic Diels-Alder ReactionLecture 3: LUMO-Lowering Organocatalysis

11

•  Finally, let’s rationalise the stereochemical outcome of the reaction:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2000,122,4243

•  Secondary orbital (diene filled π bonds to empty C=N π* orbital) interactions stabilise the ENDO transition state. Aldehyde and methylene bridge on opposite sides.

redraw

Reaction

redraw(after hydrolysis)

N

N Me

Me

MeO

Bn

H CHO

(R)

(R)

(R)

(R)

ReactionNN Me

Me

MeOPh

on oppositesides

blocks top face

H

NN Me

Me

MeOPh

H

(R)

(R)

Page 132: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Organocatalytic Diels-Alder ReactionLecture 3: LUMO-Lowering Organocatalysis

12

•  An intramolecular version of this reaction has also been reported:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2005,127,11616

•  Secondary orbital (diene filled π bonds to empty C=N π* orbital) interactions stabilise the ENDO transition state. Highlighted groups are on the same side.

H

CH3CN

cycloadduct70% yield>90% d.e.92% e.e.

(20 mol%)(S)

(R)

N

NH

t-Bu

MeO

Bn

CHO

Ph

HCHO

Ph

H

(R)(S)

ReactionNN t-Bu

MeOPh

on the sameside

blocks top face

HPhH

NN

t-BuMe

OPh

on the sameside

blocks top face

HPhHH

Page 133: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Total Synthesis of Solanapyrone DLecture 3: LUMO-Lowering Organocatalysis

13

•  This product was elaborated to marine metabolite solapyrone D:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2005,127,11616

•  The simple elaboration to biologically active compounds is a testament to the power of organocatalytic methodology.

1) MeOTs, K2CO3 2) LDA, methyl formate

71% yield>90% d.e.90% e.e.

CH3CN

(20 mol%)

N

NH

t-Bu

MeO

Bn

CHO

Me

HCHO

Me

H

TMSO

OMe

OTMS

TiCl4

HMe

H

HO

O

1) DMP2) DBU

O

OMe

HMe

H

O

O O

HMe

H

O

O OMe

O H

solanapyrone D

Page 134: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Conjugate AdditionLecture 3: LUMO-Lowering Organocatalysis

14

•  Indoles can be employed in enantioselective conjugate addition:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2002,124,1172

(20 mol%)

CH2Cl2-H2O

O

H

N

NH

t-Bu

MeO

Bn

aldehyde82% yield92% e.e.

+

MeNMe

O

H

Me NMe

NN t-Bu

MeOPh

blocks top face

HMe

Nuc

Reaction

(after hydrolysis)

O

Me

H

H

NMe

(R)

(R)

iminium Re face exposed

Page 135: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Conjugate Addition – Class ExampleLecture 3: LUMO-Lowering Organocatalysis

15

•  Many alternative nucleophiles have been used in related processes. Determine the major product for the reaction shown below:

P.M.Pihkoetal.,Chem.Rev.,2007,107,5416.

•  Highly versatile approach – only one face of iminium is exposed to nucleophile.

O

H +

Ph

N

NH Me

Me

MeO

Bn

CH2Cl2-H2O

(20 mol%)MeN

Page 136: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Total Synthesis of (-)-Flustramine BLecture 3: LUMO-Lowering Organocatalysis

16

•  MacMillan has applied this methodology towards the total synthesis of the marine alkaloid (-)-flustramine B

D.W.C.MacMillanetal.,Proc.Nat.Acad.Sci.USA.,2010,107,20648

(20 mol%)CH2Cl2-H2O

O

H

N

NH

t-Bu

MeO

Bn

N

MeMe

BocHN

Br N

MeMe

Br

NBoc

H

O

1) NaBH42) MsCl

3) NO2PhSeCN, H2O2

N

MeMe

Br

NBoc

H

Me

Me Me

Grubbs'metathesis N

MeMe

Br

NBoc

H

Me

Me

1) TMSI2) NaBH4, (CHO)n

N

MeMe

Br

NMe

H

Me

Me

78% yield90% e.e.

(−)-Flustramine B

Page 137: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Other Catalysts for Conjugate AdditionLecture 3: LUMO-Lowering Organocatalysis

17

•  Diarylprolinol silyl ether organocatalysts have also been used for conjugate additions:

Y.Hayashietal.,Angew.Chem.Int.Ed.,2006,45,6853.

•  Large OTMS and aryl groups control iminium geometry and shield the top (Re) face.

EtOH

aldehyde85% yield94% e.e.

+

Reaction

(after hydrolysis)

NH

ArAr

OTMSAr = (3,5-CF3)C6H3

(10 mol%)

N

Ar ArOTMS

(R)

O

H

Ph

O

H

PhMeO

O

OMe

O

CO2Me

CO2Me

blocks top face O

Ph H(R)

iminium Si-face exposed

PhH

Nuc

CO2MeMeO2C

Page 138: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective ReductionLecture 3: LUMO-Lowering Organocatalysis

18

•  Nature uses NADH to ezymatically reduce (hydrogenate) substrates:

Y.Hayashietal.,Angew.Chem.Int.Ed.,2006,45,6853.

•  Hantzsch esters can serve as NADH mimics and are organic reductants.

•  Provides the basis of an enantioselective organocatalytic reduction of enals.

ON

NH2

O

OH OH

OPOO

O

POO

O

O

OH OH

N

NN

N

NH2

H H

R1 R2

NH H

N

NH

R

histidine residue

active siteNADH reduction

R4

N

R1

R3

R2

NH

MeMe

MeO2C CO2MeH H

Hantzsch esterNADH mimic

Page 139: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Organocatalytic ReductionLecture 3: LUMO-Lowering Organocatalysis

19

•  MacMillan employed hantzsch esters as NADH mimics for enantioselective reduction:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2005,127,32.

•  Tert-butyl group controls iminium geometry and blocks the Si-face.

CHCl3

aldehyde91% yield93% e.e.

+

Reaction

(after hydrolysis)

(10 mol%)(S)

O

H

Ph

O

H

Ph Me

blocks bottom face

O

Ph Me(S)

Me NH

MeMe

MeO2C CO2MeH H

N

NH

t-Bu

MeO

H

NN

MeO

Me MeMePh

Me

"H"

iminium Re-face exposed

H

Page 140: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalytic Cascade ReactionsLecture 3: LUMO-Lowering Organocatalysis

20

•  Considering the mechanism of iminium organocatalysis reveals an opportunity:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2005,127,15051.

•  Can the enamine intermediate be trapped with an electrophile other than H+ to generate difunctionalised products?

NH

N

R1R1

O

- H2Oenamine

intermediateR2 R2

Nuc

N

R1

R2 Nuc*

+

E

N

R1

R2 Nuc*

E *

H2O

O

R1

R2 Nuc

E

*

*α,β-difunctionalisedaldehyde products

Page 141: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalytic Cascade ReactionsLecture 3: LUMO-Lowering Organocatalysis

21

•  MacMillan showed that iminium-enamine cascades can be achieved:

D.W.C.MacMillanetal.,J.Am.Chem.Soc.,2005,127,15051.

•  The facial selectivity in both steps is controlled by the catalyst.

EtOAc

aldehyde79% yield80% d.e.97% e.e.

+(20 mol%)

(S)

O

H

Me

O

H

Me

N

NH

t-Bu

MeO

iminium Re-face exposed

O

Me

+

OCl

ClCl

Cl

ClCl

substrate nucleophile electrophile

Bn

Cl

OMe

(S)

NN t-Bu

MeOPh

blocks top face

Me

NucH enamine Si-face

exposed

NN t-Bu

MeOPh

blocks top face

MeH

Nuc

H

E

then

Page 142: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Organocatalytic Cascade ReactionsLecture 3: LUMO-Lowering Organocatalysis

22

•  Employing hypervalent iodine reagents permits access to epoxides in high ee:

D.W.C.MacMillanetal.,Tetrahedron.,2006,62,11413.

•  Initial nucleophilic attack generates an electrophile for intramolecular cyclisation

CH2Cl2

epoxide100% yield

93% e.e.+

(20 mol%)O

H

Me (R)

(S)

IO

Ph

N

NH

t-Bu

MeO

Bn O

H

MeO

iminium Re-face exposed

NN t-Bu

MeOPh

blocks top face

Me

OHIPh

NN t-Bu

MeOPh

MeH

Hthen

OPhI

Page 143: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Iminium Organocatalysis Cheat SheetLecture 3: LUMO-Lowering Organocatalysis

23

•  For iminium organocatalysis, you must remember the following key information:

•  The iminium activation mode requires primary or secondary amine organocatalysts and non-enolisable aldehyde or ketone substrates.

P.M.Pihkoetal.,Chem.Rev.,2007,107,5416.

NH

CO2HN

NH

MeO

Ph Me

MeMe

NH OTMS

PhPh + many others!

•  In order to rationalise the stereochemistry of reactions involving iminiums you must:

1) Identify whether the catalyst operates by bifunctional activation (via hydrogen bonding) or steric control.

2) Carefully consider the possible configurations (e.g. E vs Z) and conformations (e.g. s-cis vs s-trans) of the key iminium intermediate.

3) Draw a suitable 3D-representation of the transition state.

Page 144: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

An Overview of OrganocatalysisLecture 3: LUMO-Lowering Organocatalysis

24ForanexcellentoverviewseeD.Romoetal.,Nat.Prod.Rep.,2014,31,1318.

•  Organocatalysis is now a thoroughly established member of the synthetic toolbox, with a large number of generic activation modes known.

Covalent Activation Modes Non-Covalent Activation Modes

R2

N

Enamine (di-, tri-, tetra-enamine) Catalysis

R2

N

Iminium Catalysis

R1 R2

O

Phosphine Catalysis

R1

P

Cat

O

C(1)-Enolate (di-enolate)Catalysis

Cat

O

Acyl ammonium/azoliumCatalysis

R1

R1

R1

OH

N-Heterocyclic Carbene Catalysis

R1

RN

RN

CatO

R1

C(2)-EnolateCatalysis

O

R1

C(3)-EnolateCatalysis

Cat R2

N

SOMO CatalysisR1

R1 R2

XR2

HO

PO

Brønsted AcidCatalysis

R1 R2

XR

Phase-transferCatalysis

NR4

R1 R2

XR2

OP

O

Chiral AnionCatalysis

R1 R2

X

Hydrogen BondingCatalysis

H HRN NR

S

•  Let’s now focus on LUMO-lowering organocatalysis beyond iminium activation.

Page 145: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

LUMO-Lowering Catalysis Beyond Iminium ActivationLecture 3: LUMO-Lowering Organocatalysis

25P.M.Pihkoetal.,Chem.Rev.,2007,107,5416.

•  So far we have discussed iminium organocatalysis as a method of β-functionalisation of α,β-unsaturated carbonyl compounds:

•  The iminium activation mode has the following key characteristics:1)  It is a covalent activation mode – the catalyst is covalently bound to the substrate.

2)  It is an electrophilic (LUMO-lowered) activation mode – it reacts with nucleophiles.

3)  It employs primary and secondary amine Lewis base organocatalysts and α,β-unsaturated aldehyde/ketone substrates.

R4

N

Iminium Organocatalysis

R1

R3

R2

Nuc

Page 146: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

LUMO-Lowering Catalysis Beyond Iminium ActivationLecture 3: LUMO-Lowering Organocatalysis

26D.Luptonetal.,Synthesis.,2014,46,1823.

•  Iminium catalysis is extremely powerful, but it is primarily limited to aldehyde and ketone substrates and does not extend to esters, amides etc.

•  There is an alternative way to generate chiral ester equivalents, known as (α,β-unsaturated) acyl cation organocatalysis.

H

ON

NH

MeO

Bn MeMe

N

N

MeO

Bn MeMe N

NH

MeO

Bn MeMe

X = OR, NR2

no condensationR

R

X

O

R

N

N

MeO

Bn MeMe

R

XH

R Cat

O

acyl cationcatalysis

Cat

O

α,β-unsaturated acyl cation catalysis

R

Page 147: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

LUMO-Lowering Catalysis Beyond Iminium ActivationLecture 3: LUMO-Lowering Organocatalysis

27D.Luptonetal.,Synthesis.,2014,46,1823.

•  Let’s begin by considering acyl cation catalysis:

•  A wide variety of Lewis base organocatalysts can be used to generate these species:

N

OMe

N

OHNNN Ph

O

P Ph

Tertiary Amines N-Heterocyclic Carbenes Phosphines

•  Let’s look at the key characteristics of this organocatalytic activation mode.

R LB

O When LB = Tertiary amine, acyl ammoniumWhen LB = N-heterocyclic carbene, acyl azoliumWhen LB = Phosphine, acyl phosphonium

Page 148: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Acyl Cation Organocatalytic Activation ModeLecture 3: LUMO-Lowering Organocatalysis

28D.Luptonetal.,Synthesis.,2014,46,1823.

•  Acyl cations are widely employed as activated ester equivalents:

•  The acyl cation activation mode has the following key characteristics:

1)  It is a covalent activation mode – the catalyst is covalently bound to the substrate.

2)  It is an electrophilic (LUMO-lowered) activation mode – it reacts with nucleophiles.

3)  It employs tertiary amine, phosphine and N-heterocyclic carbene Lewis base organocatalysts

4)  It can be accessed from a wide variety of electrophilic substrates including acid chlorides, anhydrides, carboxylic esters/acids etc.

Acyl Cation Activation Mode

R LB

O

Nuc

Page 149: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Anhydrides as Precursors for Acyl CationsLecture 3: LUMO-Lowering Organocatalysis

29D.Luptonetal.,Synthesis.,2014,46,1823.

•  Acyl cations can be accessed from anhydride precursors:

•  Once generated, the acyl cation can undergo substitution with a nucleophile to access the product with regeneration of the catalyst.

•  This process amounts to an acyl transfer reaction and has been used across a wide spectrum of substrates.

•  Let’s consider the general catalytic cycle for this organocatalytic activation mode.

LB Nuc-H

Anhydride Acyl CationR1 O

O

R1

O

R LB

O

R Nuc

O

Page 150: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Acyl Cation Organocatalysis – General MechanismLecture 3: LUMO-Lowering Organocatalysis

30

•  We can draw the following catalytic cycle for acyl cation organocatalysis:

D.Luptonetal.,Synthesis.,2014,46,1823.

•  Remember that a variety of other substrates can serve as acyl cation precursors, including acid chlorides, carboxylate esters etc. Let’s look at some specific examples.

Nuc-H

Lewis baseorganocatalyst

LB

AnhydrideR1 O

O

R1

O

Acyl CationR LB

O

R Nuc

O

Page 151: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

The Steglich RearrangementLecture 3: LUMO-Lowering Organocatalysis

31

•  In 1970, Steglich reported that DMAP catalysed the rearrangement of O-acylated azlactones to their corresponding C-acylated isomers:

W.Steglichetal.,TetrahedronLetters.,1970,54,4727

•  For this class of organocatalytic reaction we must be able to:

1)  Know how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

NO

OMeO

Me

Ph

O

tert-amyl alcoholazlactone80% yield

(10 mol%)

NMe2N

NO

O

Me

Ph

MeO

O

Page 152: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

The Steglich RearrangementLecture 3: LUMO-Lowering Organocatalysis

32

•  First let’s consider the organocatalytic activation mode:

W.Steglichetal.,TetrahedronLetters.,1970,54,4727

•  We have the following information:

1)  A tertiary amine Lewis base organocatalyst is used

2)  The substrate has contains an electrophilic carbonate functional group.

•  This reaction proceeds via the acyl ammonium activation mode.

NO

OMeO

Me

Ph

O

tert-amyl alcoholazlactone80% yield

(10 mol%)

NMe2N

NO

O

Me

Ph

MeO

O

Page 153: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

The Steglich RearrangementLecture 3: LUMO-Lowering Organocatalysis

33

•  Now let’s consider the curly arrow pushing mechanism:

W.Steglichetal.,TetrahedronLetters.,1970,54,4727

•  Chiral Lewis base organocatalysts have also been employed in this reaction.

NO

OMeO

Me

Ph

O

tert-amyl alcoholazlactone80% yield

(10 mol%)

NMe2N

NO

O

Me

Ph

MeO

O

NO

OMeO

Me

Ph

O

NMe2N

NO

O

Me

Ph

N

NMe2

O OMe

Page 154: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

The Steglich RearrangementLecture 3: LUMO-Lowering Organocatalysis

34

•  For example, Vedejs has employed chiral DMAP derivatives to access the azlactone products in high enantioselectivity:

E.Vedejsetal.,J.Am.Chem.Soc.,2003,125,13368

•  To rationalise the stereochemical outcome of the reaction is beyond the scope of this course.

•  Why might the products be useful building blocks for synthetic applications?

NO

OPhO

Me

Ar

O

tert-amyl alcoholazlactone95% yield91% e.e.

(1 mol%)

NO

O

Me

Ar

PhO

ON

NMe2 OAcPh

PhPh

Ar = 4-OMeC6H4

Page 155: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

LUMO-Lowering Catalysis Beyond Iminium ActivationLecture 3: LUMO-Lowering Organocatalysis

35D.Luptonetal.,Synthesis.,2014,46,1823.

•  Let’s now think about α,β-unsaturated acyl cation catalysis:

•  Again, a wide variety of Lewis base organocatalysts can be used to generate these species:

N

OMe

N

OHNNN Ph

O

P Ph

Tertiary Amines N-Heterocyclic Carbenes Phosphines

•  Let’s look at the key characteristics of this organocatalytic activation mode.

LB

O When LB = Tertiary amine, α,β-unsaturated acyl ammoniumWhen LB = N-heterocyclic carbene, α,β-unsaturated acyl azoliumWhen LB = Phosphine, α,β-unsaturated acyl phosphoniumR

Page 156: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

α,β-Unsaturated Acyl Cation Organocatalytic Activation ModeLecture 3: LUMO-Lowering Organocatalysis

36D.Luptonetal.,Synthesis.,2014,46,1823.

•  α,β-Unsaturated acyl cations are currently an extremely active area of research in organocatalysis:

•  The α,β-unsaturated acyl cation activation mode has the following key characteristics:

1)  It is a covalent activation mode – the catalyst is covalently bound to the substrate.

2)  It is an electrophilic (LUMO-lowered) activation mode – it reacts with nucleophiles.

3)  It employs tertiary amine, phosphine and N-heterocyclic carbene Lewis base organocatalysts

4)  It can be accessed from a wide variety of electrophilic substrates including α,β-unsaturated acid chlorides, fluorides, anhydrides, carboxylic esters/acids etc.

α,β-Unsaturated Acyl Cation Activation Mode

LB

ONuc

R

Page 157: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Acid Chlorides as Precursors for α,β-Unsatured Acyl CationsLecture 3: LUMO-Lowering Organocatalysis

37D.Luptonetal.,Synthesis.,2014,46,1823.

•  α,β-Unsaturated acyl cations can be accessed from acid chloride precursors:

•  Once generated, the α,β-unsaturated acyl cation can undergo attack with di-nucleophiles to access the product with regeneration of the catalyst.

•  This process amounts to a formal β-functionalisation, reminiscent of iminium organocatalytic processes.

•  Let’s consider the general catalytic cycle for this organocatalytic activation mode.

LB

α,β-unsaturatedacid chloride

α,β-Unsaturated Acyl Cation

Cl

O

R LB

O

R

NucNuc

R

Nuc

O

Nuc

*

Page 158: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Acyl Cation Organocatalysis – General MechanismLecture 3: LUMO-Lowering Organocatalysis

38

•  We can draw the following catalytic cycle for acyl cation organocatalysis:

D.Luptonetal.,Synthesis.,2014,46,1823.

•  Remember that a variety of other substrates can serve as α,β-unsaturated acyl cation precursors, including α,β-unsaturated fluorides, anhydrides etc.

Lewis baseorganocatalyst

LB

α,β-unsaturatedspecies

X

O

R

α,β-Unsaturated Acyl Cation

LB

O

R

NucNuc

R

Nuc

O

Nuc

*

Page 159: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Dihydropyridone SynthesisLecture 3: LUMO-Lowering Organocatalysis

39

•  In 2013, Chi reported the NHC catalysed LUMO activation of α,β-unsaturated esters for reaction with enamides:

Y.R.Chietal.,Angew.Chem.Int.Ed.,2013,52,8592.

•  For this class of organocatalytic reaction we must be able to:

1)  Know how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

Ph OR

O

R = 4-NO2C6H4

THF

(20 mol%), DBU+

Me Ph

NTs

NNN Mes

O

BF4

N

OTs

PhPh

dihydropyridone73% yield99% e.e.

Page 160: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Dihydropyridone SynthesisLecture 3: LUMO-Lowering Organocatalysis

40

•  First let’s consider the organocatalytic activation mode:

Y.R.Chietal.,Angew.Chem.Int.Ed.,2013,52,8592.

•  We have the following information:

1)  A N-heterocyclic carbene Lewis base organocatalyst is used

2)  One reactant contains an electrophilic α,β-unsaturated ester. The other is a nucleophilic enamide.

•  This reaction proceeds via the α,β-unsaturated acyl azolium activation mode.

Ph OR

O

R = 4-NO2C6H4

THF

(20 mol%), DBU+

Me Ph

NTs

NNN Mes

O

BF4

N

OTs

PhPh

dihydropyridone73% yield99% e.e.

Page 161: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective Dihydropyridone SynthesisLecture 3: LUMO-Lowering Organocatalysis

41

•  Now let’s consider the curly arrow pushing mechanism:

Y.R.Chietal.,Angew.Chem.Int.Ed.,2013,52,8592.

•  You will not be expected to explain the enantioselectivity of this process.

Ph OR

O

R = 4-NO2C6H4

THF

(20 mol%), DBU+

Me Ph

NTs

NNN Mes

O

BF4

N

OTs

PhPh

dihydropyridone73% yield99% e.e.

Ph LB

O

Ph

NTsH

Ph LB

OPh

NTs

Ph LB

OPh

HNTs

Page 162: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective γ-Lactam SynthesisLecture 3: LUMO-Lowering Organocatalysis

42

•  In 2013, Romo reported the tertiary amine catalysed LUMO activation of α,β-unsaturated acid chlorides for reaction with aminomalonates:

D.Romoetal.,Angew.Chem.Int.Ed.,2013,52,13688.

•  For this class of organocatalytic reaction we must be able to:

1)  Know how the organocatalyst activates the substrate (activation mode)

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

Me Cl

O

THF

(20 mol%), DBU+

TsHN CO2Me

CO2Meγ-lactam

73% yield93% e.e.

N

OMe

N

OTMS

TsN

Me

MeO2CMeO2C O

Page 163: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective γ-Lactam SynthesisLecture 3: LUMO-Lowering Organocatalysis

43

•  First let’s consider the organocatalytic activation mode:

D.Romoetal.,Angew.Chem.Int.Ed.,2013,52,13688.

•  We have the following information:

1)  A tertiary amine Lewis base organocatalyst is used

2)  One reactant contains an electrophilic α,β-unsaturated acid chloride. The other is a nucleophilic aminomalonate.

•  This reaction proceeds via the α,β-unsaturated acyl ammonium activation mode.

Me Cl

O

THF

(20 mol%), DBU+

TsHN CO2Me

CO2Meγ-lactam

73% yield93% e.e.

N

OMe

N

OTMS

TsN

Me

MeO2CMeO2C O

Page 164: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective γ-Lactam SynthesisLecture 3: LUMO-Lowering Organocatalysis

44

•  Now let’s consider the curly arrow pushing mechanism:

D.Romoetal.,Angew.Chem.Int.Ed.,2013,52,13688.

•  You will not be expected to explain the enantioselectivity of this process.

Me Cl

O

THF

(20 mol%), DBU+

TsHN CO2Me

CO2Meγ-lactam

73% yield93% e.e.

N

OMe

N

OTMS

TsN

Me

MeO2CMeO2C O

Page 165: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Enantioselective γ-Lactam SynthesisLecture 3: LUMO-Lowering Organocatalysis

45

•  Products were elaborated to neurotransmitter inhibitor baclofen:

D.Romoetal.,Angew.Chem.Int.Ed.,2013,52,13688.

Ar Cl

O

THF

(20 mol%), DBU+

TsHN CO2Me

CO2Allylγ-lactam

74% yield99% e.e.

N

OMe

N

OTMS

TsN

Ar

MeO2CAllylO2C O

Ar = 4-ClC6H4

Pd2(dba)3, PPh3HCO2NH4

TsN

Ar

MeO2C O>90% d.e.

SmI2HN

Ar

MeO2C ONaOHOH

O

ArNH2

Baclofen

Page 166: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Acyl Cation Organocatalysis Cheat SheetLecture 3: LUMO-Lowering Organocatalysis

46

•  For acyl cation organocatalysis, you must remember the following key information:

•  Acyl cations and α,β-unsaturated acyl cations can be accessed using a variety of tertiary amines, N-heterocyclic carbenes and phosphines.

D.Luptonetal.,Synthesis.,2014,46,1823.

•  Acyl cations and α,β-unsaturated acyl cations can be generated from a range of electrophilic substrates including acid chlorides/fluorides/esters/acids/anhydrides.

•  You will be expected to be able to identify the specific organocatalytic activation mode involved in a given reaction and provide a curly arrow pushing mechanism.

•  Rationalising the stereochemical outcome of reactions involving organocatalytic acyl cations is beyond the scope of this course.

NNN R1

R2

N

SNPh

i-PrP Ph

Page 167: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Tackling Organocatalysis Questions – Strategy and TipsLecture 3: LUMO-Lowering Organocatalysis

47

•  When faced with an unseen problem you should be able to:

1)  Identify how the organocatalyst activates the substrate (activation mode). This will be restricted to those described throughout in this course.

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

3)  Rationalise the stereochemical outcome of the reaction (enantio- and/or diastereocontrol if relevant) by drawing an appropriate 3D transition state. This is expected for organocatalytic processes involving enamine or iminium intermediates.

•  Let’s think of the best general strategy for solving organocatalysis problems…

Me

O

Me

O

O NH

CO2H

(3 mol%)DMF

O

O

Me

OH

Bicycle>90% d.e. 97% e.e.

Page 168: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Tackling Organocatalysis Questions – Strategy and TipsLecture 3: LUMO-Lowering Organocatalysis

48

1)  Identify how the organocatalyst activates the substrate (activation mode).

Step a) Consider the organocatalyst and classify it as either a secondary amine, tertiary amine, phosphine, N-heterocyclic carbene etc.

Step b) Next consider the reagents used in the reaction. What types of functional groups are present? e.g. ketones, aldehydes, acid chlorides, α,β-unsaturated species.

Step c) Finally, look at the product of the reaction. Identify between which atoms new bonds are formed? Consider how these new bonds are likely to be formed?

•  Following this protocol should allow you to provide a reasoned justification for the organocatalytic activation mode chosen.

Me

O

Me

O

O NH

CO2H

(3 mol%)DMF

O

O

Me

OH

Bicycle>90% d.e. 97% e.e.

Page 169: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Tackling Organocatalysis Questions – Strategy and TipsLecture 3: LUMO-Lowering Organocatalysis

49

2)  Draw a curly arrow pushing mechanism that rationalises product formation.

Step a) Consider the activation mode. The first step in the curly arrow pushing mechanism will be reaction of the organocatalyst with one of the reagents.

Step b) Next look at the product of the reaction. Identify between which atoms new bonds are formed? Consider how these new bonds are likely to be formed?

•  Following this protocol should allow you to draw a suitable curly arrow pushing mechanism. Remember to draw FULL mechanisms, with no steps left out!

Me

O

Me

O

O NH

CO2H

(3 mol%)DMF

O

O

Me

OH

Bicycle>90% d.e. 97% e.e.

Page 170: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Tackling Organocatalysis Questions – Strategy and TipsLecture 3: LUMO-Lowering Organocatalysis

50

3) Rationalise the stereochemical outcome of the reaction (enantio- and/or diastereocontrol if relevant) by drawing an appropriate 3D transition state.

Step a) Consider the key activated species. What is the lowest energy form? (must consider the most stable configuration and conformation in many cases)

Step b) Next look at the product of the reaction. What is the stereochemistry within the product? Does it agree with the 3D transition state representation you have drawn.

•  Do not think of every reaction as a unique case. Each activation mode has a general stereochemical model associated with it. Determine the activation mode, consider how the catalyst will function, and draw a suitable 3D transition state model.

Me

O

Me

O

O NH

CO2H

(3 mol%)DMF

O

O

Me

OH

Bicycle>90% d.e. 97% e.e.

Page 171: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Tackling Organocatalysis Questions – Strategy and TipsLecture 3: LUMO-Lowering Organocatalysis

51

The single best advice – practice, practice, practice!

Page 172: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

Key learning objectives:

•  Traditional LUMO lowering of carbonyl compounds using Lewis acids.

•  The iminium organocatalytic activation mode: definition; general catalytic cycle; various intra- and intermolecular functionalisation reactions; curly arrow pushing mechanisms; stereochemical rationale.

•  Iminium-enamine organocatalytic cascades.

•  Alternative LUMO-lowering organocatalytic activation modes.

•  Acyl cation organocatalytic activation mode: acyl ammonium/azolium intermediates; definition; general catalytic cycle; various intra- and intermolecular functionalisation reactions; curly arrow pushing mechanisms.

•  α,β-Unsaturated acyl ammonium/azolium activation modes: definition; general catalytic cycle; various intra- and intermolecular functionalisation reactions; curly arrow pushing mechanisms.

Lecture 3: LUMO-Lowering Organocatalysis

52ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM

Page 173: CH3404 Asymmetric Synthesis of Pharmaceuticals and Natural ... · • In 1990, Dieter Seebach (one of the world’s leading organic chemists) wrote an essay on the future of organic

To reinforce your understanding of the contents of this lecture, please refer to:

•  Organic Chemistry 2nd Ed. (J. Clayden, N. Greeves and S. Warren, Oxford University Press, 2012, ISBN 978-0-19-927029-3). Chapter 41 is particularly relevant.

•  New Frontiers in Asymmetric Catalysis (K. Mikami and M. Lautens, Wiley, 2007). Downloadable from University Network. DOI: 10.1002/0470098007

•  Catalytic Asymmetric Synthesis 3rd Ed. (I. Okima, Wiley, 2010). Downloadable from University Network. DOI: 10.1002/9780470584248

•  Prof. MacMillan Short-Course: www.princeton.edu/chemistry/macmillan/research/

•  Leading review articles on iminum catalysis (Chem. Rev., 2007, 107, 5416) and acyl cation catalysis (Synthesis, 2014, 46, 1823)

Lecture 3 Revision

53ForfurtherinformationseeLearningCentral:CH3404/LearningMaterials/LCM